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Nucleic acid is the basic genetic material of all life forms on earth. In recent years, nucleic 
acid technology has assumed an essential role in widespread fields ranging from medicine to 
agriculture. In the field of molecular diagnostics, nucleic acid analysis has become widely adopted 
due to their high specificity, sensitivity and their capability for multiplexing. The critical first step 
in nucleic acid analysis is sample preparation, which involves isolation and purification of 
DNA/RNA from diverse samples, such as blood and serum. Compared to rapid advances in 
genomic analysis methods, DNA extraction techniques have remained nearly unchanged over the 
past 20 years. While spin columns and magnetic microparticles dominate due to their speed and 
ease-of-use, these methods fragment DNA and are incapable of sufficient DNA quality for the 
newest long-read sequencing and genome mapping technologies. Moreover, despite all the 
technological advancements, nucleic acid techniques that allow large-scale multiplexed analysis of 
polymorphic genetic loci remain needed for theoretical and practical nucleic acid research, such as 
the study of oncogenic mutations and genetic disease diagnosis. In addition, the cost-effectiveness 
of infectious disease diagnosis by nucleic acid analysis counts on the multiplex scale in panel 
testing. So far, solid-phase probe hybridization, PCR and LCR are the three domain assays for 
locus-specific analysis but none of them can be adapted to the practical needs. Therefore, 
developing novel and effective strategies for large-scale multiplexed analysis is still a compelling 
need. 
In this thesis, we present advanced platforms for multiplexed analysis of nucleic acids 
including 1) a simple silica nanomembrane-based method to extract high molecular weight, high 
purity DNA, 2) a Ratiometric Fluorescence Coding strategy for multiplexed detection of nucleic 
acids and 3) an easy single-molecule, fluorescence spectroscopic method to measure absolute 
telomere lengths in a variety of DNA samples. 
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We start by discussing the existing DNA extraction methods and current strategies for 
expanding the multiplexed detection capacity of nucleic acid amplification testing. We also 
introduce the confocal single-molecule spectroscopy and its capability for screening analytes that 
are not amendable to amplification-based analysis (Chapter 1). Then, we introduce the 
thermoplastic silica nanomaterial named Nanobind and demonstrate its capability of extracting 
DNA > 5.7 Mb within 45 mins surpassing any existing methods (Chapter 2). Next, we present and 
demonstrate our Ratiometric Fluorescence Coding strategy for multiplexed detection of DNA 
targets from six infectious diseases and the potential for further expanding its multiplexing 
capability (Chapter 3). Finally, we implement the confocal single-molecule fluorescence 
spectroscopy to measure the absolute telomere lengths and demonstrate the accurate detection of 
telomeres as short as 100 bp with high reproducibility and profiling of telomere lengths in human 
cancer cell lines and primary cells (Chapter 4). 
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Chapter 1  
1. Multiplexed Nucleic Acid Analysis 
1.1 Background 
Nucleic acid, one kind of macromolecules present in almost all the cells of most organisms, 
is one of the most basic substance of life. These macromolecules store, transmit and express genetic 
information of cells and allow organisms to transfer genetic information from one generation to the 
next. Based on their different chemical components, nucleic acids can be divided into two types: 
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). In most cells, DNA plays the major role 
in the storage, copying and transmission of genetic information, while RNA directs the synthesis 
of proteins.  
Since the landmark discovery in 1953 reporting the double helix structure of DNA [1], 
there has been a rapid advancement of nucleic acid technology, including recombinant cloning 
technology [2, 3], polymerase chain reaction (PCR) [4], sequencing [5, 6], CRISPR technology [7, 
8], etc. These technologies have been applied and created new commercial opportunities in a wide 
range of fields. For example, a plethora of medical products, such as insulin and vaccines, have 
been commercially prepared using recombinant DNA technology for the treatment of many 
diseases including cancer [9, 10]. Moreover, as the great advances in the development of 
sequencing techniques, the release of whole genome sequence data for a number of organisms have 
opened a path for personalized genetic diagnostics and treatment [11, 12]. At the same time, the 
use of nucleic acid technology has become commonplace in the field of agriculture (e.g. transgenic 
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insect-resistant crops) [13], animal farming (e.g. food safety) [14, 15]  and forensic science (e.g. 
DNA typing).  
Among these technological advancement, nucleic acid-based tests/assays have become 
widely accepted in molecular diagnostics due to their high specificity, sensitivity and their ability 
to analyse more than one genetic markers simultaneously in each sample [16]. Compare with 
conventional methods, nucleic acid-based analysis such as PCR, DNA microarrays [17, 18], and 
automated sequencing techniques can provide more molecular information with easier operation 
and rapid turnaround time. For example, in the case of pathogen detection, nucleic acid analysis 
takes much shorter time compared with traditional culture-based methods [19, 20] and enables 
detection of the presence of pathogen DNA noninvasively from asymptomatic individuals [21]. In 
general, nucleic acid analysis involves two major steps: 1) sample preparation including the 
isolation and purification of nucleic acids, and 2) sample detection for the characterization of DNA 
or RNA of interest (Figure 1.1). 
1.2 Nucleic Acid Isolation 
Isolation of nucleic acids from blood, serum, or plasma, is a critical step in nucleic acid 
analysis since the quality of the recovered nucleic acid can affect the performance in downstream 
reactions [22]. Conventionally, liquid phase extraction techniques, such as Phenol/Chloroform 
precipitation method, are widely used [23-25]. Although this approach yields DNA of better quality, 
it is laborious, time-consuming and highly operator-dependent. Solid phase extraction techniques 
are gaining popularity these days [26-28] and they are often the methods of choice when processing 
a large number of samples. Solid phase nucleic acid extraction via silica adsorption is one of the 
most common techniques used in modern molecular biology, yet the precise mechanism is not fully 
understood. It relies on the selective adsorption of nucleic acids to a stationary phase (e.g. porous 
silica membrane) or a mobile solid phase (e.g. paramagnetic silica microparticles). As a result, the 
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vast majority of commercial nucleic acid extraction kits are performed using either spin columns 
containing porous silica membranes or silica paramagnetic microparticles [29-31]. These spin 
columns and micro/nano particles can provide rapid, ease-of-use and generally high purity of DNA 
extraction, while on the other hand, induce high shearing forces to fragment DNA during flow and 
mixing, resulting in DNA sample of relatively poor integrity [32, 33]. 
 The ability to obtain high molecular weight DNA with high purity has become 
increasingly important to ensure accurate downstream genetic analyses such as 3rd generation 
sequencing. The 3rd generation technologies offer long read lengths surpassing that of 2nd 
generation and Sanger technologies [34, 35]. For example, Pacific Biosciences' SMRT technology 
offers read lengths up to 30 kb. The ability to sequence large sections of unfragmented genomic 
DNA could greatly aid in decoding whole genomes containing long repeat sequences [36]. In gene 
therapy and DNA vaccines, high binding capacity could be extremely useful in isolating industrial 
quantities of long plasmids [37-39]. In genetic analysis of telomeres [40] or functional analysis of 
chromosomal rearrangements such as copy number variation [41], high molecular weight input 
DNA reduces the chance that fragmentation will occur in a region of interest. Therefore, a method 
that allows high molecular weight DNA extraction with high yield and purity is under demanding. 
1.3. Multiplexed Nucleic Acid Amplification Testing 
After sample preparation, the extracted DNA or RNA will be utilized for subsequent 
characterization and detection via techniques including nucleic acid amplification testing (NAAT), 
DNA microarray, sequencing, etc. NAAT, which is a technique that involves the amplification and 
detection of nucleic acids for diagnosis, has emerged as a popular technique for the diagnosis of 
infectious diseases, such as sextually transmitted diseases [42], and inherited diseases, such as 
cancer [43, 44], etc. Indeed, NAAT methods, such as real-time PCR [45, 46], have been widely 
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employed for nucleic acid detection and clinical diagnosis due to their high sensitivity, specificity, 
and rapid turnaround time. 
Although NAAT methods have become the cornerstone for molecular diagnosis of diseases, 
expanding the multiplexed detection capacity of NAAT remains an important objective. 
Multiplexed NAAT essentially means the ability to simultaneously analyse multiple 
biomarkers/targets within one sample at the same time, which is particularly useful for clinical 
diagnosis. For example, the common approach for clinical diagnosis of a patient with nonspecific 
infection is to prescribe broad spectrum antibiotics and wait for the patient’s response. However, 
the antibiotics may not work at all if the causative pathogen is viral. Then if the physician suspects 
a particular pathogen and asks for a laboratory test for it, which however, may takes multiple 
individual tests to rule out the suspected pathogens until the right one is found. This procedure may 
lead to a long diagnosis time (several hours to even days) and further delay the time for effective 
treatment. On the other hand, with a multiplexed test capable of screening the patient’s sample for 
multiple suspected bacterial and viral pathogens simultaneously, the physician will be able to 
identify the pathogen within a single test and expedite the diagnosis process.  
Multiplexed NAAT can be accomplished through diverse ways, among which the most 
commonly used approach is to simultaneously use multiple target-specific probes, each being 
labelled with a fluorophore of a distinct colour, in a single assay, such as multiplexed real-time 
PCR with Taq-man probes [47, 48]. However, such one-color-one-target scheme has a limited 
capacity of multiplexing because of the spectral overlaps between fluorophores, which restrict the 
number of fluorophores that can be used within a single assay. Several strategies have been 
developed as alternatives to the one-color-one-target scheme to increase the multiplexing capacity 
of NAAT methods.  For example, Multiplex Ligation-dependent Probe Amplification (MLPA) [49, 
50] utilizes a panel of probes with distinct lengths that are ligated after target-specific hybridization 
and then amplified via PCR to generate amplicons with distinct lengths. The multi-length 
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amplicons in a single reaction – each encoding a specific target – can then be separated and 
identified using capillary electrophoresis, which however, requires expensive equipment and adds 
complexity to this assay. Yet another example that obviates electrophoresis is post-PCR melt 
temperature (Tm) analysis that can distinguish the amplicons generated from specific targets for 
multiplexed detection [51, 52]. Unfortunately, the number of amplicons/targets that can be 
identified via Tm is constrained by the temperature resolution and noises from primer dimers, which 
are hard to avoid in PCR. Therefore, there still remains a need for improving the multiplexing 
capacity of NAAT methods. 
1.4. Single Molecule Detection of Nucleic Acid 
Though amplification-based nucleic acid detection has been the keystone for nucleic acid 
analysis, such enzymatic amplification procedure introduces some challenges for quantitative 
analysis of nucleic acids. For example, there are errors associated with the amplification procedure 
that causes nucleic acid sequence misrepresentation, such as base substitutions [53, 54], which may 
result in false positives in single nucleotide polymorphism (SNP) detection. Moreover, the 
amplification bias, especially the GC bias in PCR amplification has long been recognized as the 
major factor that affects the amplification efficiency, causing uneven amplification of different 
nucleic acid sequences [55, 56]. In addition, there are several classes of analytes that are not 
amendable to amplification-based analysis including nucleic acid sequences with tandem repeats, 
such as telomere [57, 58] and trinucleotide repeat in Huntington’s disease [59]. Amplification-
based methods cannot provide absolute quantification of the tandem repeat length and always suffer 
from allelic dropout during PCR [60]. 
Due to these challenges, single molecule detection (SMD) techniques have merged as a 
powerful approach for nucleic acid analysis, which enables the observation of single nucleic acid 
molecule with unparalleled detection sensitivity and quantification capability [61, 62]. With the 
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advances in laser-based fluorescence detection in the past half-century, a variety of optical SMD 
techniques for nucleic acid analysis, which measure individual molecules in solution or on a solid 
surface, have been developed [63-65]. Optical SMD in solution is usually performed using confocal 
fluorescence spectroscopy, in which a laser beam is focused into a femtoliter-size detection volume 
and used to excite single fluorescently-labeled molecules passing through the volume (Figure 1.2). 
The femtoliter detection volume defined by a high-numerical-aperture and a confocal pinhole is 
capable of greatly reducing the background noise from Raman scattering or undesirable fluorescent 
impurities compared with bulk detection with large volume (~microliter). Due to its high signal-to-
noise ratio, signal from even a single fluorescently-labeled molecule can be effectively detected 
and distinguished from background. Moreover, a fluorescent burst is detected only when a 
fluorescently-labeled molecule passing through the small detection volume, thus the total number 
of molecules in sample can be measured by counting the number of fluorescent bursts. With these 
unique advantages, optical SMD is suited as an ideal platform for quantitative analysis of low-
abundance nucleic acid [66], DNA sizing [67], etc. 
However, conventional confocal SMD suffers from two prototypical technical limitations: 
low mass defection efficiency and quantification artifacts due to the non-uniform Gaussian 
detection volume. We have developed a new implementation of SMD, termed as cylindrical 
illumination confocal spectroscopy (CICS) [68], which enables highly quantitative, continuous 
flow single molecule analysis with high mass detection efficiency and high uniformity. CICS is 
designed to be a highly sensitive and high throughput platform that can be generically integrated 
with any microfluidic systems with additional microfluidic components. By employing one-
dimensional beam shaping to create a highly uniform sheet-like detection curtain that spans the 
entire cross-section of a microchannel, CICS achieves near 100% mass efficiency, <10% relative 
SD in burst heights, and a high signal/noise ratio. It is far less sensitive to thresholding artifacts 
than traditional SMD and is significantly more accurate at determining both burst rate and burst 
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parameters. This platform has been used to size circulating DNA from serum without amplification 
[69]. By direct hybridization of unamplified nucleic acids with fluorescently-labeled probes, we 
expend to implement CICS for quantitative analysis of tandem repeats. 
1.5. Summary and Thesis Objectives 
In this thesis, we propose to develop an advanced platform for multiplexed analysis of 
nucleic acid including a simple silica nanomembrane-based method to extract high molecular 
weight, high purity DNA, a Ratiometric Fluorescence Coding strategy for multiplexed detection of 
nucleic acid and implementation of the confocal single-molecule spectroscopy for the measurement 
of absolute telomere lengths in a variety of DNA samples.  
In the first chapter, we introduce a novel magnetic thermoplastic silica nanomaterial called 
Nanobind for high molecular weight DNA extraction. A simple heat-shrinking process is utilized 
to create a high density of micro- and nano-scale silica lamella that capture DNA using a unique 
tethering mechanism and harbor it from fragmentation. We compare Nanobind with commercial 
paramagnetic particles and spin columns, and demonstrate our extraction method enables high 
yields, high quality and high molecular weight DNA far surpassing that of any existing silica 
technology. We then demonstrate the high molecular weight and low damage of Nanobind DNA 
using single molecule, real-time (SMRT) sequencing, which generates exceptional quality long-
read libraries and lead to some of the longest reads seen to date on Pacific Biosciences' platform. 
Next, we present a new multiplexed detection approach termed Ratiometric Fluorescence 
Coding, in which we encode each nucleic acid target with a specific ratio between two standard 
fluorophores. In Ratiometric Fluorescence Coding, we employ the padlock probe chemistry to 
encode each nucleic acid target with a specific number of binding sites for two probes labelled with 
different fluorophores. Coupling the padlock probes with either rolling circle amplification (RCA) 
or hyperbranched rolling circle amplification (HRCA), we transform each nucleic acid target into 
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a specific template that allows hybridization with the fluorescently-labelled probes at pre-designed 
ratios, thereby achieving multiplexed detection. Furthermore, a droplet-based microfluidic system 
is coupled with Ratiometric Fluorescence Coding to facilitate high-throughput screening for 
multiplexed analysis. We demonstrate our approach for multiplexed detection of DNA targets from 
six infectious diseases and demonstrate its potential for further expanding the multiplexing 
capability of NAATs. 
In the final chapter, we describe an easy single-molecule, fluorescence spectroscopic 
method named PHAST (hybridization and analysis of single telomere) that permits the profiling of 
absolute telomere lengths in any DNA sample. We demonstrate the ability of our method to 
measure the absolute telomere lengths with high reproducibility and minimal calibration. Moreover, 
we demonstrate its accurate detection of telomeres as short as 100 bp using cloned telomere 
standards, and have determined the distribution of telomere lengths in human cancer cell lines, 








Figure 1.1. Major steps in nucleic acid analysis workflow 
In nucleic acid research, we are interested in studying nucleic acids from all kinds of samples, such 
as blood, cell lines, bacteria, plants etc. The first critical step is sample preparation, which involves  
nucleic acid extraction and purification.  After sample preparation, the extracted DNA or RNA will 
be used for detection and analysis via a variety of nucleic acid detection techniques including 






Figure 1.2. A schematic view of a confocal SMD spectroscope 
Components of a typical SMD spectroscope include a laser source, collimating lens for excitation 
source, dichroic mirror, objective, sample, emission bandpass filter, focusing lens, confocal pinhole 
and single photon detector. The detection volume on a confocal SMD spectroscope (blue shaded 
area; bottom right) is defined by the focused excitation laser beam (bright red) and the collection 
efficiency of the microscope. The confocal pinhole in the setup (typically 50-100 urn) serves to 






Chapter 2  
2. High Molecular Weight DNA Extraction via 
Magnetic Thermoplastic Nanomaterial  
2.1 Background 
DNA extraction from biological samples, such as blood, serum, or plasma, is a critical step 
for downstream genetic analysis. The ability to obtain large quantities of high molecular weight 
(HMW) and high-quality DNA is of rising importance as genomic analysis tools become 
increasingly sophisticated and the implications of long-range genomic information are realized. In 
DNA sequencing, 3rd generation technologies, such as Pacific Biosciences' SMRT technology and 
Oxford Nanopore's MinION technology, offer long read lengths greatly surpassing Sanger 
sequencing that facilitate de novo sequence assembly and the deciphering of complex repeat 
sequences [34, 35, 41, 70]. Barcoding technologies such as 10X Genomics' GemCode offer the 
potential to link myriad short reads in Mb-sized long-reads [71]. Recent genome mapping methods 
such as BioNano Genomics' Irys technology and OpGen's Argus technology require DNA that is 
hundreds of kb to Mb in length in order to characterize chromosomal rearrangements and long-
range genetic information such as copy number variation and inversions [72, 73].  
Despite rapid advances in such genomic tools, few advances have been made in DNA 
extraction since silica extraction technology was first introduced [74, 75]. To achieve high DNA 
binding capacities (i.e. extracted DNA per unit area) and extraction yields (i.e. total amount of 
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extracted DNA), these methods rely on the adsorption of DNA to micro- and nanostructured 
materials with high surface area to volume ratios, such as magnetic microparticles [29, 76-79] or 
spin columns containing porous materials [78, 80]. These methods have enjoyed widespread 
adoption due to their speed, ease-of-use, and generally high performance (i.e. high purity and 
efficiency). However, the shear forces imposed by the existing silica extraction methods tend to 
fragment DNA such that tedious precipitation methods (e.g. phenol-chloroform or salting out) and 
multi-day gel plug extractions [81] remain the only option when the highest DNA quality is 
required.  
In this chapter we introduce a conceptually different approach to silica-based high 
molecular weight DNA extraction by developing a novel magnetic silica nanomaterial called 
Nanobind. This non-porous, planar nanomembrane contains a hierarchical layering of microscale 
folds and nanoscale silica lamella. In contrast to microparticles and spin columns where nucleic 
acids can be sheared by particle mixing or by flow through porous matrices, the high surface area 
of silica lamella on Nanobind protect nucleic acid from shear force-induced fragmentation by 
harboring it in a condensed, tentacle conformation that enables the extraction of vast amounts of 
ultra-high molecular weight (UHMW) DNA. This gentle process ensures rapid isolation (<45 
minutes) of high quality, megabase (Mb) DNA, containing minimal damage such as nicks and 
abasic sites, which can be used to generate high quality, single molecule sequencing libraries 
capable of superior read lengths. Furthermore, Nanobind is easily magnetized to facilitate sample 
processing. Herein, we explore Nanobind's unique binding mechanism, the fabrication parameters 
affecting silica lamella surface topography, and characterize the DNA extraction performance. We 
also perform a thorough comparison against the three most commonly used DNA extraction 
methods and conclude by using Nanobind extracted DNA for long-read sequencing using Pacific 
Biosciences single molecule, real-time (SMRT) sequencing technology. 
2.2 Experimental Details 
15 
 
2.2.1 Nanobind Fabrication 
Non-magnetic Nanobind was fabricated by depositing silicon dioxide onto both sides of a 
20 µm thick polyolefin film (Uline, Pleasant Prairie, WI) using electron beam evaporation. Then 
the oxide-deposited polyolefin film was baked in a convection oven at 165 °C for 3 minutes to heat 
shrink and induce surface wrinkling. The film shrunk isotropically by 78% in each linear direction. 
A 6 mm disk was then created using a metal punch. Magnetic Nanobind was fabricated by 
depositing 100 nm of silicon dioxide on side 1 of a 20 µm thick polyolefin film (Uline, Pleasant 
Prairie, WI) and then depositing a layer stack containing 20 nm silicon dioxide, 30 nm iron, and 20 
nm silicon dioxide. Heat shrinking and die punching were performed identically to non-magnetic 
Nanobind. 
2.2.2 BET Measurements 
The BET surface area was measured using a Micromeritics ASAP 2020 physisorption 
analyzer (Micromeritics, Norcross, GA). Sample tubes containing 85 and 65 disks of the 100 nm 
oxide and 200 nm oxide Nanobind substrates, respectively, were degassed for 10 hrs at 90 °C. 
Krypton adsorption isotherms were then measured at 77 K and relative pressures ranging from 0.03 
to 0.5. The BET surface area was calculated from the isotherms using the standard method [82]. 
2.2.3 Nanobind DNA Extraction 
To eliminate differences from extraction chemistry, Nanobind DNA extraction was 
performed using the same buffer system as microparticle and spin column extractions. All 
extractions were performed using a single 6 mm Nanobind disk in a 1.5 mL microcentrifuge tube. 
Unless otherwise indicated, non-magnetic Nanobind was used. λ DNA extraction was performed 
by adding 200 µL of Buffer AL (Qiagen, Valencia, CA) to 10 µg of λ DNA (New England Biolabs, 
Ipswich, MA) and mixing well. Cultured cell extraction was performed by adding 50 μL of 10 
mg/μL proteinase K (Life Technologies, Carlsbad, CA) and 200 μL of Buffer AL to trypsinized 
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cells that had been resuspended in PBS and incubating at 55 °C for between 10 minutes to 1 hr. For 
both sample types, a 6 mm Nanobind disk and 300 µL of isopropanol was added, and the mixture 
was rotated at room temperature for 10-30 minutes. This allowed DNA to bind to the Nanobind 
surface. After binding, the liquid in the tube was pipetted out and discarded. Then 700 µL of buffer 
AW1 (Qiagen, Valencia, CA) was added to wash the Nanobind substrate. After pipetting out and 
discarding buffer AW1, 500 µL of buffer AW2 (Qiagen, Valencia, CA) was added to wash the 
Nanobind substrate a 2nd time. The AW2 washing step was repeated once more, and all the liquid 
was removed leaving only the Nanobind substrate and bound DNA in the tube. To ensure complete 
evaporation of any residual liquid, the tube was heated at 55 °C for 1-2 minutes with the cap open. 
Afterwards, 100 µL of DI water was added into the microcentrifuge tube, and the tube was 
incubated at 70°C for 10-20 minutes to elute the DNA. Finally, the eluent was transferred into a 
new tube. 
2.2.4 UHMW Nanobind DNA Extraction 
Extractions were performed identically to above except buffer AL, buffer AW1, and buffer 
AW2 were replaced by custom formulations developed by Circulomics called CL1, PW, and SW, 
respectively. Wide bore pipette tips and gentle pipetting were also used to minimize DNA shear 
due to fluid handling. 
2.2.5 Microparticle DNA Extraction 
Microparticle DNA extraction was performed with the same buffers as Nanobind using the 
Qiagen BioSprint 96 DNA protocol. First, lysis was performed identically to the Nanobind 
extraction process above. Then 30 µL of MagAttract Suspension G magnetic particles (Qiagen, 
Valencia, CA) was added to the sample. The tube was incubated at room temperature for 15 minutes 
for binding and then placed on a magnetic holder to pull the particles aside such that the liquid 
could be removed. After the tube was removed from the magnetic holder, 500 µL of buffer AW1 
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was added and mixed with the microparticles. Then the supernatant was discarded by placing the 
tube on the magnetic holder again and pipetting out. Next, the magnetic particles were washed two 
more times with 500 µL of buffer AW2, and the tube containing the magnetic particles was dried 
at 55 °C for 3 minutes with an open cap. After all the liquid in tube had evaporated, 100 µL of 
water was added, and the mixture was incubated at 70 °C for 20 minutes. Finally, the tube was put 
onto the magnetic holder to facilitate the collection of the eluent. 
2.2.6 Nanobind DNA Preparation for SEM 
After binding genomic DNA onto the Nanobind surface, the Nanobind disk with DNA was 
fixed with buffer (3% formaldehyde, 1.5% Glutanraldehyde in 0.1 M NaCacodylate, 5mM Ca2+, 
2.5% Sucrose, pH 7.4) at room temperature for 10 minutes and then washed in 0.1 M Cas/2.5% 
sucrose pH 7.4 three times. The disk with DNA was then post-fixed with Palade’s 1% OsO4 for 15 
minutes at room temperature. and rinsed in Kellenberger UA (20% Acetate-veronal stock, 28% 0.1 
M HCl, 5 g/L Uranyl Acetate and ddH2O, adjusting pH to 6 with UA) for 1 min at room 
temperature. After a quick rinsing in ddH2O, the disk was dehydrated with graded series of cold 
ethanol (50%, 70%, 95%, 100%) and then washed in fresh 100% ethanol at room temperature. 
Finally the Nanobind disk with DNA was air dried at room temperature for 30 mins prior to SEM 
scanning. 
2.2.7 Spin Column DNA Extraction 
Spin column DNA extraction was performed using the QIAamp DNA Mini kit (Qiagen, 
Valencia, CA) according to the manufacturer's protocol. 
2.2.8 Phenol-Chloroform DNA Extraction 
Phenol-chloroform DNA extraction began by adding 300 µL of lysis buffer (50mM Tris, 
50mM EDTA and 2% SDS) and 50 µL of 10 mg/mL proteinase K (Life Technologies, Carlsbad, 
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CA) to the cultured cells. After incubation at 55°C overnight, the digested sample was transferred 
into a MaXtract High Density phase lock gel tube (Qiagen, Valencia, CA) and mixed with 350 µL 
of 25:24:1 phenol:chloroform:isoamyl alcohol by shaking until the mixture turned milky white. 
The tube was then centrifuged at 15,000 x g for 5 minutes, and the upper aqueous phase containing 
the DNA was pipetted out of the phase lock gel tube into a fresh microcentrifuge tube. Next, 35 µL 
of pH 7.5 ammonium acetate and 700 µL of 100% ethanol was added, and the mixture was 
incubated at -20°C overnight to precipitate the DNA. Then, the sample was centrifuged at 13,000 
rpm for 10 minutes. After discarding the liquid waste, the DNA pellet was washed in 300 µL of 
75% ethanol, and the tube was centrifuged a 2nd time at 13,000 rpm for 5 minutes. All the ethanol 
was discarded after the washing step, leaving only the DNA pellet in the tube. The tube was 
incubated at 60°C for around 1 to 2 minutes with the cap open to evaporate any remaining ethanol. 
Finally, 100 µL of DI water was added into the tube, and the tube was incubated at 50°C for 20 
minutes to rehydrate the DNA pellet. 
2.2.9 DNA Quantification and UV Absorbance 
Quant-iT PicoGreen (Invitrogen, Eugene, OR) was used to quantify the isolated DNA. The 
PicoGreen dye was first diluted 1:200 in 1X TE buffer (Invitrogen, Eugene, OR) while the isolated 
DNA sample was diluted 1:10 or 1:20 in 1X TE buffer. 50 µL of the diluted DNA sample was 
mixed with 50 µL of the diluted PicoGreen dye solution, and the mixture was incubated in the dark 
at room temperature for around 5 minutes. The fluorescence was then measured on a NanoDrop 
3300 fluorospectrometer (Thermo Scientific, Wilmington, DE). The sample DNA concentrations 
were determined by comparing the fluorescent signal against a λ DNA serial dilution standard curve. 
The purity of isolated DNA was evaluated by UV absorbance using a NanoDrop 1000 UV-Vis 
spectrophotometer (Thermo Scientific, Wilmington, DE). 
2.2.10 Agarose Gel Electrophoresis 
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The size of the extracted DNA was evaluated using a 0.5% agarose gel in 1X TAE buffer 
and running at 8V/cm for 90 minutes. The gel was stained using GelStar nucleic acid gel stain 
(Lonza, Allendale, NJ) and imaged with a Typhoon 9400 variable mode imager (GE Healthcare, 
Piscataway, NJ).  
2.2.11 Pulsed Field Gel Electrophoresis 
Pulsed field gel electrophoresis was performed using a 1% Megabase certified agarose gel 
(Bio-Rad, Hercules, CA) in 0.5X TBE buffer and running at 14° C, 120° angle, 6V/cm, and 35s - 
90s switch ramping for 22 hours on a CHEF DR III system (Bio-Rad, Hercules, CA). The gel was 
stained using SYBR Gold (ThermoFisher, Eugene, OR) and imaged with a Typhoon 9400 variable 
mode imager (GE Healthcare, Piscataway, NJ). The reference DNA sample was a lambda ladder 
(CHEF DNA Size Standard #170-3635, Bio-Rad, Hercules, CA). For analysis of UHMW DNA, 
PFGE was performed using a 1% Megabase certified agarose gel (Bio-Rad, Hercules, CA) in 1X 
TAE buffer and running at 14° C, 106° angle, 2V/cm, and 1800s switch time for 68 hours and an 
S. pombe ladder (Bio-Rad, Hercules, CA).  
2.2.12 Single Molecule Free Solution Hydrodynamic Separation 
All DNA samples were stained separately at 5 ng/µL in 10 mM EACA, 10 mM Bis-Tris 
buffer with 1 µM TOTO-3 and 500 pM of a reference dye (Alexa647) for at least 1 hour in the dark. 
The reference DNA sample was a 5 kb ladder (CHEF DNA Size Marker #170-3624, Bio-Rad), 
which was stained under the same conditions as the extracted genomic DNA samples. All 
separations were performed in the same 600 cm effective length, 10 µm ID fused silica 
microcapillary (Polymicro Technologies, Phoenix, AZ). The loading and elution buffers consisted 
of 10 mM EACA, 10 mM Bis-Tris, and 25 mM NaCl. Sample plugs were loaded into the capillary 
using a 10 second, 50 psi injection. Separation was performed at 225 psi. Capillaries were flushed 
with clean elution buffer between samples. 
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The raw APD counts were collected in 0.1 ms bins. The raw APD data were then 
normalized for APD dead time and quantum efficiency to obtain fluorescence photon counts. The 
normalized fluorescence traces could then be analyzed via single molecule counting or bulk 
fluorescence analysis.19 For bulk fluorescence analysis, the fluorescence traces were re-binned into 
6 second bins and smoothed in OriginPro (OriginLab, Northampton, MA) using the Savitzky-Golay 
method with a window size of 5 points and a polynomial of order 2. Background fluorescence was 
calculated as the average of one minute of data immediately prior to the beginning of each DNA 
separation, and was subtracted from the total fluorescence before plotting. The retention times 
across all the samples were normalized against the reference dye retention time. 
2.2.13 qPCR Analysis 
qPCR was performed using 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM 
MgSO4, 0.1% Triton® X-100, 10 mM dNTPs, 200 nM PCR primers, and 1.25 units per 50 µL of 
Taq polymerase (New England Biolabs, Ipswich, MA) in a 25 µL reaction volume. PCR primers 
were synthesized (Integrated DNA Technologies, Coralville, IA) to amplify a 148 bp region of the 
human GAPDH gene (Fwd Primer: 5’ - GAA GGT CGG AGT CAA CGG ATT T / Rev Primer: 
5’-ATG GGT GGA ATC ATA TTG GAA C). qPCR was performed in a CFX96 Touch (Bio-Rad, 
Hercules, CA) using EvaGreen (Bio-Rad, Hercules, CA) with the following thermal cycling 
parameters: 30 sec at 95°C, 35 cycles of 30 sec at 95°C, 1 minutes at 60°C and 1 minutes at 72°C, 
and a final extension of 10 minutes at 72°C. Threshold cycle (Ct) was determined using Bio-Rad's 
CFX Manager software. Each DNA extraction sample was used to generate 10-fold serial dilutions 
and analyzed in triplicate.  
2.2.14 SMRTbell Library Preparation and Sequencing 
DNA library preparation and sequencing was performed at Pacific Biosciences according 
to the standard >30kb SMRTbell library preparation guide available on PacBio SampleNet. In short, 
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5–20 μg of high-quality, genomic DNA for each sample was verified via Qubit to quantify the 
amount of dsDNA present. After quantification, each sample was diluted to ~250 ng/μl in PacBio 
elution buffer. For several of the samples, DNA amounts were quantified after shearing, as the high 
molecular weights of these samples made quantification difficult. Samples were subject to needle 
shearing by passing the sample through a 26G needle five to forty times (26G needles from SAI 
Infusion Technologies, 1 mL Luer-Lok tip syringes from Becton Dickinson) The sheared genomic 
DNA was then repurified using a 0.45× AMPure PB purification step to ensure removal of very 
short fragments (<1 Kb) and biological contaminants before proceeding with the enzymatic steps 
in the library preparation process.  
Following library construction, the DNA templates were size selected for a lower cutoff of 
30 kb using a BluePippin instrument (Sage Science, MA, USA). Libraries were subject to a post 
size-selection damage repair step, and the sizes of the resultant libraries were confirmed using 
pulsed field gel electrophoresis (CHEF Mapper XA, Bio-Rad). Sequencing was performed on the 
PacBio RS II using P6 polymerase binding and C4 sequencing kits. Samples were MagBead loaded 
with on chip concentrations ranging from 25 to 50 pM with 360 min acquisition times. 
2.3 Silica Lamella Fabrication and Characterization  
The high surface area of nanoscale lamella structures on Nanobind are fabricated via a 
simple and inexpensive 2-step process comprising evaporation of silicon dioxide onto both sides 
of polyolefin (PO) film and heat-shrinking in an oven (Figure 2.1A). Film stresses generated by 
the heat shrinking process lead to a hierarchical layering of microscale polyolefin folds and 
nanoscale silica lamella that can act as a high surface area, low shear substrate for DNA extraction. 
Optionally, a magnetic sandwich layer, which imparts a dark gray hue to the white substrate, may 
be deposited inline to facilitate magnetic manipulation. In this case, silicon dioxide is used to 
sandwich an iron layer such that DNA adsorption can continue to occur on both sides of the 
22 
 
Nanobind substrate while also passivating the metallic iron layer from unwanted buffer interactions. 
DNA isolation is performed using a standard bind, wash, and elute protocol that parallels spin 
column and magnetic microparticle extraction (Figure 2.1B) and can be completed in less than 45 
minutes using either non-magnetic or magnetic processing. Magnetic processing can further be 
performed in either manual or automated format using standard robotic instruments (Figure 2.2). 
Nanobind DNA is captured via a novel tentacle binding mechanism in which a 
macromolecular entanglement of DNA is tethered to the silica substrate (i.e. the white disk) at a 
single end and extends deep into solution in a manner akin to jellyfish tentacles (Figure 2.1C). The 
low shear format prevents fragmentation and allows Nanobind to act as a seed upon which high 
molecular weight DNA tentacles grow. As cellular input increases, the DNA assembles into sheet- 
and sack-like structures, enabling a small area of substrate to capture vast amounts of DNA. SEM 
images (Figure 2.3) show that HMW genomic DNA assembles into sheet-like structures and that 
tether across silica lamellae surface. 
High surface area is created by the hierarchical layering of nanoscale silica lamella and 
microscale polyolefin folds. As seen in Figure 2.4, the surface topography can be fine-tuned by 
varying the amount of silicon dioxide that is deposited prior to heat shrinking. With 2 nm of silicon 
dioxide, the oxide layer largely conforms to the microfolds of the underlying polyolefin film. With 
20 nm and 50 nm of silicon dioxide, nanoscale silica wrinkles and lamella begin to develop on top 
of the microfolds as the film stresses begin to overwhelm the adhesion between the oxide and 
underlying polyolefin. With 100 nm, 150 nm, and 200 nm of oxide, a high density of silica lamella 
begin to form and progressively increase in size and number as film stresses cause the silicon 
dioxide to delaminate and fracture. In addition, rather than fully detach and release, the silica 
lamella remain stably anchored in place by a combination of mechanical interlocking, residual 
adhesive portions, and lamina-lamina adhesion. Proper design of the layer structures further ensures 
that addition of the optional magnetic sandwich does not affect silica lamella surface topography 
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(Figure 2.4G). SEM analysis also shows that the lamella remain stably anchored before and after 
DNA extraction with no observable degradation (Figure 2.5).  
 This hierarchical layering of features provides a substantial increase in surface area over 
a planar substrate. Using Brunauer-Emmett-Teller (BET) gas adsorption, we measured the surface 
area of the 100 nm and 200 nm oxide Nanobind substrates. Each 6 mm diameter disk resulted in 
BET surface areas of 9.33 cm2 and 9.74 cm2, respectively, a 35-fold increase over the planar 
substrate (Figure 2.6). 
2.4 Nanobind DNA Binding Mechanism 
To investigate the effects of silica lamella topography on DNA binding, we performed 
extractions using the 0 nm oxide (i.e. no oxide control), 20 nm oxide (i.e. low density lamella), 100 
nm oxide (i.e. high density lamella), 200 nm oxide (i.e. high density lamella), and unshrunk 100 
nm oxide (i.e. flat oxide control) Nanobind substrates. As expected based on SEM and BET 
analysis, DNA extraction efficiency progressively grew with oxide thickness and the expected 
surface area (Figure 2.7A). Both the 100 nm and 200 nm oxide Nanobind substrates had high 
efficiency and recovered nearly all of the input DNA. In contrast, the unshrunk 100 nm oxide 
Nanobind substrate recovered only moderate amounts of DNA while the 0 nm oxide Nanobind 
substrate recovered very little DNA, demonstrating that a high density of silica lamella is critical 
for high extraction yields. The non-magnetic and magnetic Nanobind substrates can be used 
interchangeably with no noticeable difference in performance (Figure 2.8). 
Next, we attempted to measure Nanobind binding capacity by performing extractions on 
cultured cells. As seen in Figure 3b, extraction yield increased linearly across the entire range of 
cell inputs. With 25x106 MCF-7 cells, the 6 mm Nanobind extracted over 175 µg of DNA, 
representing 100% efficiency and a binding capacity of 188,000 µg/m2. This binding capacity is 
100-1,000,000-times greater than previously reported values for silica microparticles (<.03 µg/m2 
24 
 
to 2,100 µg/m2) [29, 76-80].The true Nanobind binding capacity likely exceeds this as binding 
saturation had not yet been reached. It is noteworthy that with 25x106 cells input, over 600 µg of 
RNA was also co-purified, further illustrating the high binding capacity. 
A direct comparison against commercial spin columns and magnetic microparticles 
showed that with moderate cell input (Figure 2.9A), Nanobind obtained twice the amount of DNA, 
but with a high cell input (Figure 2.9B), Nanobind yielded 10 to 30-times the amount of DNA. We 
predict this difference would continue to grow with further increases in cell input. The 1.5 mL 
format spin column and microparticle processes used herein are capable of high efficiency when 
extracting 10 to 20 µg of DNA but decrease in efficiency at higher inputs as the binding surfaces 
become saturated. Using Nanobind, over 200 µg of DNA could be extracted and eluted into a 
volume as small as 50 µL, resulting in DNA concentrations as high as 4 µg/µL. Nanobind also 
demonstrated high repeatability with extraction-to-extraction CV of only 12%.  
Despite the increased extraction yield, the Nanobind surface area (9.33 cm2) was actually 
less than that typically used in microparticle extractions (45-275 cm2) [76]. Thus, we postulated 
that the extreme binding capacity was actually a result of the unique tentacle binding mechanism. 
Thus, large genomic DNA fragments, which more easily form macromolecular tentacles than short 
DNA fragments, should result in higher extraction yields. To test this, we measured Nanobind 
binding capacity using λ DNA that had been heat fragmented from 48 kb progressively down to 
400 bp (Figure 2.10). As seen in Figure 2.7c and Figure 2.10, Nanobind is exceptionally efficient 
at capturing large DNA. Full length λ DNA exhibited a binding capacity 80-times greater than 400 
bp DNA. The true difference is potentially even greater as the full length λ DNA had not reached 
binding saturation at 100 µg of input. This dramatic increase in large DNA binding capacity can be 
attributed to the decrease in surface area necessary to tether a few pieces of large DNA as opposed 
to many pieces of small DNA.  
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As evident in Figure 2.7C and Figure 2.4G, the bound genomic DNA does not lie in a 
strictly prone conformation. Previous studies have modeled the physics of DNA adsorption [29, 76, 
83, 84] while attempting to untangle complex electrostatic, salt-bridging, and entropic binding 
effects [29, 76, 78]. The simplest models assume that DNA lies prone against the silica substrate, 
bound by multiple contact points along the length of the molecule.[5] This mechanism implies that 
binding capacity is limited predominantly by substrate surface area and DNA packing density, with 
a maximum surface coverage of 20-30% [29, 79]. Studies have further proposed that binding 
conformation can be affected by parameters such as buffer conditions, surface properties, packing 
density, and, potentially, DNA length [76]. Through the use of the low shear, planar, non-porous 
Nanobind, we are able to bias the DNA binding away from the typical prone conformation towards 
a tethered conformation that is particularly efficient for high molecular weight DNA extraction. It 
is possible that due to this unique mechanism binding saturation may never reasonably occur. 
2.5 DNA Extraction Comparison 
We then compared Nanobind (NB) against phenol-chloroform (PC), spin column, and 
magnetic microparticles by extracting genomic DNA from 3x106 cultured MCF-7 cells using all 
four methods. First, we compared the length of the extracted DNA using single molecule free 
solution hydrodynamic separation (SML-FSHS) [67, 85]. SML-FSHS uses single molecule 
sensitivity to enable accurate determination of large DNA size and concurrent detection of minute 
amounts of DNA fragmentation. As shown in Figure 3d, Nanobind and phenol-chloroform DNA 
had high molecular weights with length centered around 100 kb. Nearly all of the DNA was greater 
than 50 kb with substantial portions greater than 100 kb. Magnetic particle DNA showed increased 
fragmentation with very little DNA >90 kb while spin column DNA displayed obvious shearing 
and appeared as a broad smear. Agarose gel electrophoresis confirmed these trends (Figure 2.11) 
while pulsed field gel electrophoresis further showed that Nanobind extracted DNA up to 300 kb 
with an average length around 150 kb (Figure 2.7E). Under UV absorbance analysis, all four 
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systems showed high purity with 260/280 ratios between 1.99 to 2.04 and 260/230 ratios between 
2.10 and 2.25 (Figure 2.7F and Figure 2.12). When qPCR was used to analyze 10-fold serial 
dilutions of the previously extracted DNA, all 4 samples exhibited the expected log-linear relation 
between DNA input and threshold cycle Ct (Figure 2.7G and Figure 2.13). At all dilutions, 
Nanobind and phenol-chloroform extracted DNA resulted in lower Ct values than the microparticle 
or column extracted DNA. As the same number of cells was input into each extraction, the lower 
Ct value is likely a combination of factors such as higher extraction yield, lower amounts of 
carryover PCR inhibitors (e.g. residual organic solvents, salts, etc), and lower DNA damage. 
2.6 Long-Read Single Molecule Sequencing 
We selected Nanobind and phenol-chloroform extracted DNA to create long-insert 
SMRTbell libraries for single molecule sequencing as these samples exhibited the highest molecular 
weights. For Nanobind DNA, an on-substrate RNase digestion and wash were added to remove RNA 
contamination and obtain pure genomic DNA. Both samples were capable of supporting libraries 
with a 30 kb lower cutoff, the maximum cutoff possible using the current Blue Pippin size-selection 
method (Figure 2.14). The mean maximum subread lengths per zero-mode waveguide (ZMW) 
produced by the phenol-chloroform and Nanobind libraries were 20.6 kb and 20.1 kb, respectively. 
The subread N50 values, based on the longest reads obtained per ZMW, were 29.4 kb for phenol-
chloroform (Figure 2.15A) and 28.0 kb for Nanobind (Figure 2.15B), indicating that 50% of the 
sequenced bases are in subreads greater than 29.4 and 28.0 kb, respectively. For both samples, 
approximately 10% of subreads were in excess of 40 kb, and the longest reads were near 70 kb. 
Consistent with these outstanding subread length distributions, the frequency of damage-related 
sequencing terminations in these libraries is estimated to be less than one in 500 kb, indicating five- 
to ten-fold less damage than that typically observed in libraries of this size. 
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To further test the capabilities of Nanobind, we developed an UHMW process using a custom 
buffer set and protocol to further reduce shear. Using this process, extracted DNA size rose from 300 
kb up to greater than 5.7 Mb (Figure 2.15C and Figure 2.16). To our knowledge, this is the largest 
DNA ever extracted using a standard, silica-based bind, wash, and elute protocol. The UHMW DNA 
was then used to generate a SMRTbell library with 30 kb cutoff as before and subjected to single 
molecule sequencing. The resultant library produced a mean maximum subread length of 16.7 kb, a 
subread N50 value of 24.6 kb, and maximum subread length of 73.7 kb (Figure 2.15D, E). While 
these sequencing metrics are not as outstanding as the first set of sequencing data, they are consistent 
with libraries of the highest quality, and the differences likely reflect variability in template 
preparation and chip loading.  
2.7 Conclusion 
In this chapter, we have demonstrated Nanobind for extracting DNA with ultra high MW 
exceeding Mb in length,  low damage, and high purity. This is evidenced by both its high performance 
in qPCR and in long-read single molecule sequencing. Using Nanobind DNA, we prepared the 
highest quality long-insert libraries and generated extremely long single molecule reads, with 50% of 
the sequenced bases contained in subreads greater than 28 kb, and maximum reads in excess of 70 
kb. These read length gains have important implications for genome assembly, as there is a tradeoff 
between read length, coverage, and expected contig length in a genome assembly. These gains can 
be roughly predicted by the Lander-Waterman model [86], a widely applied model from the Sanger 
sequencing era. This model predicts that, under ideal conditions in an assembly in which all overlaps 
have been detected perfectly, expected contig length for a given coverage level should scale linearly 
with increasing read lengths (Figure 2.17A). Thus, increasing read length from 15 to 30 kb is 
predicted to increase the average contig length by two-fold. Looking at it another way, the amount of 
coverage needed to achieve a comparable expected contig length decreases with increasing read 
length (Figure 2.17B). In practice, the simplifying assumptions made by this model, particularly the 
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assumption that the genome is free of repeats, mean that this model effectively gives an upper bound 
on what is achievable.  In reality, the relationship between read length, coverage, and contig size is 
dependent on the number and length of repeats in a given genome. Longer reads additionally allow 
for sequencing through longer repeat regions, potentially allowing access to previously inaccessible 
regions of a genome and improving genome assembly.  
These data suggest that Nanobind is an excellent alternative to phenol-chloroform and gel 
plug extraction when the highest quality genomic DNA is required. Whereas these methods can take 
1-3 days and require substantial manual skill, the equivalent Nanobind extraction can be performed 
in less than 45 minutes. Nanobind offers a unique combination of high binding capacity and high 
molecular weight DNA that cannot be achieved with any existing solid phase technology. The high 
binding capacity enables high extraction yield while the short processing time and non-porous format 
render it easily incorporated into small volume, microfluidic, and automated extraction systems at µL 
to mL scales. Additionally, the ability to re-suspend into small volumes is useful in obtaining high 
concentration DNA. This suggests that Nanobind can also be used as a plug-and-play substitute for 
spin columns and microparticles in diverse research, clinical, and production applications beyond 
high molecular weight. Furthermore, by engineering Nanobind to contain a magnetic sandwich on 
one side, we are able to process samples manually using a magnetic rack or automated using a robotic 
instrument. 
Film stresses in polymer substrates have been previously used to create surfaces with 
controlled wrinkle structures [87] while heat shrinking of thermoplastic films has been used to create 
precision microfluidic channels [88] and micropatterned surfaces [89]. Alternatively, stresses within 
layer-by-layer deposition processes have been used to create superhydrophobic, hierarchical metal 
nanoflake surfaces [90]. In this chapter, we integrate these principles to create a novel hierarchical 
silica lamella surface. The underlying polyolefin film costs pennies per square foot, and the 
fabrication can be easily scaled using industrial roll-to-roll processes to create a nanostructured DNA 
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extraction substrate that is exceptionally inexpensive to produce. The extraction chemistry 
incorporated herein used off-the-shelf buffers and obtained a mixture of both DNA and RNA but high 
efficiency extractions have also been performed using our own custom buffers. For example, in the 
UHMW process, custom buffers and protocols were able to push extracted DNA length north of 5.7 
Mb, while retaining a short 45 minute process time. Future work will integrate Nanobind into other 
molecular analysis workflows including genome mapping, methylation analysis, and microRNA 
profiling from a broad array of samples including bacterial and plant cells, tissues, body fluids, and 






Figure 2.1. High molecular weight DNA extraction using the magnetic thermoplastic 
Nanobind 
(A) The hierarchical silica lamella are fabricated by depositing a thin layers of silica onto a 
thermoplastic polyolefin (PO) film, heat shrinking in an oven, and punching out a 6 mm disk of 
material. Alternatively, an silica-iron-silica sandwich may be deposited on the backside to facilitate 
magnetic processing. The white disk is a non-magnetic Nanobind substrate while the dark gray disk 
is a magnetic Nanobind substrate. (B) DNA extraction is performed using a standard bind, wash, 
and elute protocol that can be performed with or without magnetic handling. (C) Images of genomic 
DNA captured by non-magnetic Nanobind and tethered onto silica surface after cell lysis and 
mixing with IPA. The high surface area and low shear forces enable large amounts of high 
molecular weight DNA to be captured via a tethered binding mode where macromolecular tentacles 
of DNA extend from the Nanobind substrate deep into solution. From left to right are images of 
Nanobind disks bound with genomic DNA from low (2x106), moderate (7x106), and high (25x106) 




Figure 2.2. Images of magnetic Nanobind being used for manual and automated process 
Images of magnetic Nanobind being used for (A) manual processing using a Life Technologies 
DynaMag-2 magnetic tube rack and (B) automated processing using a Thermo Scientific 
KingFisher DUO. The green arrows illustrate the black magnetic Nanobind substrates attracted to 
the tube wall and to the end of the magnetic rods, respectively. Adapted with permission from [91]. 





Figure 2.3. SEM images of genomic DNA bound to Nanobind 
SEM images of genomic DNA bound to silica lamellae on a 100 nm oxide Nanobind substrate. 





Figure 2.4. SEM images of Nanobind surface topography 
The heat-shrinking process leads to a hierarchical structure of microscale polyolefin folds layered 
with nanoscale silica lamella that can be fine-tuned via oxide deposition thickness. SEM analysis 
was performed on non-magnetic Nanobind with (A) 2 nm, (B) 20 nm, (C) 50 nm, (D) 100 nm, (E) 
150 nm and (F) 200 nm of deposited silicon dioxide. g) SEM images of magnetic Nanobind show 
a similar structure of microscale folds and nanoscale lamella. Each pair of images shows the same 
material under low (left) and high magnification (right). Adapted with permission from [91]. 





Figure 2.5. SEM images of Nanobind before and after DNA extraction 
SEM images of a 100 nm oxide Nanobind substrates (A) before and (B) after DNA extraction. No 
change is seen in the surface topography demonstrating that the lamella are stably tethered. Adapted 





Figure 2.6. BET measurements for Nanobind 
BET absorption isotherms for the 100 nm oxide and 200 nm oxide Nanobind substrates. Analysis 
resulted in BET surface areas of 9.33 cm2 and 9.74 cm2, respectively. Adapted with permission 





Figure 2.7. Nanobind DNA extraction characterization and comparison 
(A) Extraction efficiency was measured as a function of Nanobind silicon dioxide thickness. The 
200 nm and 100 nm silica Nanobind substrates contain a high density of silica lamella and achieve 
high extraction efficiencies when compared to the 0 nm oxide and planar oxide controls. (n=4) (B) 
DNA extraction yield was measured as a function of cell input. No saturation was seen even at 
25x106 cells input, demonstrating that the binding capacity exceeds 188,000 µg/m2. (C) Nanobind 
binding capacity was measured as a function of DNA length. Binding capacity was significantly 
enhanced for full length λ DNA versus highly fragmented λ DNA. (n=3) (D) Single molecule free 
solution hydrodynamic separation and (E) pulsed field gel electrophoresis were performed on 
genomic DNA extracted using phenol-chloroform (PC), Nanobind (NB), magnetic microparticles 
and spin column. Red dotted lines represent the median length of DNA extracted with each method. 
Phenol-chloroform and Nanobind DNA have the highest molecular weight with average length 
around 150 – 200 kb. Spin column DNA is highly fragmented (<50 kb) while magnetic particles 
show moderate shearing with DNA with average length around 75 kb. (F) UV absorbance shows 
that all 4 methods obtain high purity nucleic acids. g) qPCR was performed on serial dilutions of 
the extracted DNA. Nanobind and phenol-chloroform DNA consistently resulted in the lowest Ct 






Figure 2.8. Comparison between non-magnetic and magnetic Nanobind 
DNA extraction was performed on either 1x106 MCF-7 cells or 4x106 MCF-7 cells using non-
magnetic and magnetic Nanobind (n=3). UV absorbance was used to determine purity and total 
nucleic acid yield while Qubit assays were used to determine DNA yield. Across extensive testing, 
no noticeable difference has been seen in yield, binding capacity, purity, or molecular weight. 






Figure 2.9. Yield comparison of Nanobind, spin column, and magnetic microparticles 
(A) With 3x106 cells input, Nanobind showed 2-fold higher yield as spin column and microparticles 
were already saturated. (B) At 25x106 cells input, Nanobind still had not reached saturation and 
showed 10-fold higher yield than microparticles and nearly 30-fold higher yield than microparticles. 





Figure 2.10. Gel image of heat sheared λ DNA used for DNA length analysis 






Figure 2.11. Gel image of DNA extracted using four different methods  
Agarose gel electrophoresis image of DNA extracted using phenol-chloroform (PC), Nanobind 
(NB), magnetic microparticles, and spin column. Adapted with permission from [91]. Copyright 






Figure 2.12. UV aborbance curves of nucleic acid extracted using four methods  
UV absorbance curves of nucleic acids extracted from 3 million cells by phenol-chloroform, 
Nanobind, magnetic microparticles, and spin column. All 4 methods obtain high purity nucleic 
acids. The extracted nucleic acids contain a mixture of DNA and RNA. Adapted with permission 






Figure 2.13. Gel image of PCR amplification products  
Agarose gel electrophoresis image of the 148 bp PCR product amplified from commercial genomic 
DNA, phenol-chloroform extracted DNA, Nanobind extracted DNA, and a water control. Adapted 






Figure 2.14. Phenol-chloroform and Nanobind DNA SMRTbell libraries size selection 
Phenol-chloroform (PC) and Nanobind (NB) DNA SMRTbell libraries size selected using a 30 kb 
cutoff. Dashed line indicates the 40 kb mark. Adapted with permission from [91]. Copyright 1999-






Figure 2.15. SMRT sequencing data for phenol-chloroform, Nanobind and UHMW Nanbind 
DNA 
>30 kb insert SMRTbell libraries prepared using a) PC and b) NB extracted DNA resulted in 
exceptional read lengths with N50 values of 29.2 kb and 27.7 kb, respectively. c) An UHMW 
extraction process was developed that increased extracted DNA size from 300 kb up to Mb range. 
d) The UHMW DNA was then used to generate >30 kb insert SMRTbell libraries that resulted in 
robust long reads with N50 values of 24 kb and longest reads of 70 kb. e) SMRT sequencing read 
metrics for all libraries. All data is based on the max subread length obtained per zero-mode 






Figure 2.16. Gel image of UHMW Nanobind DNA under PFGE condition 
Ultra high molecular weight (UHMW) Nanobind DNA from 3 separate extractions was run under 
alternate PFGE conditions to more accurately determine DNA size. When compared to the S. 
pombe ladder, UHMW DNA can be seen surpassing 5.7 Mb in size. Adapted with permission from 






Figure 2.17. Expected contig length vs read length or coverage by Lander-Waterman model 
a) Expected average contig length as a function of mean read length for 10X coverage. b) Expected 
average contig length as a function of read coverage across a range of mean read lengths for the 
human genome. Calculations are based on the Lander-Waterman model. Adapted with permission 






Chapter 3  
3. Ratiometric Fluorescence Coding Assay for 
Multiplexed Nucleic Acid Detection 
3.1 Background 
Nucleic acid amplification testing (NAAT) has emerged as a popular technique for the 
diagnosis of many diseases including cancer [43, 44], genetic disorders [92], mitochondrial 
disorders [93], and infectious diseases [42, 94, 95]. Indeed, NAAT methods such as real-time 
polymerase chain reaction (PCR) [45, 46], ligase chain reaction (LCR) [96, 97], and nucleic acid 
sequence-based amplification (NASBA) [98, 99] have been widely employed for nucleic acid 
detection because of their high sensitivity, specificity, and rapid turn-around-time. In addition, a 
number of different approaches can be coupled with NAAT to achieve multiplexed detection of 
multiple targets in a single assay, which is a particularly useful capability for clinical diagnosis of 
diseases [94, 100]. Among these approaches, which range from differentiating the melting 
temperatures of NAAT amplicons [51, 52] to assigning targets with probes that have distinct 
lengths [49, 50, 101, 102], the most commonly employed strategy has been using a target-specific, 
fluorescently-labeled oligonucleotide probe for each target nucleic acid sequence. While this “one-
color-one-target” approach is straightforward and effectively leverages the mature fluorescence 
detection infrastructure associated with NAAT methods, it unfortunately has a limited capacity of 
multiplexing because spectral overlaps between fluorophores restrict the number of fluorophores 
that can be used within a single assay. As such, there remains a need for fluorescence-based 
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approaches that extend beyond the one-color-one-target restriction and expand the multiplexing 
capacity of NAAT.  
A natural and promising extension to the one-color-one-target approach is using a unique 
combination of multiple fluorophores to encode each target sequence. A handful of strategies for 
demonstrating this approach have been reported. For example, 15-plex detection using only 4 
fluorophores has been achieved through a strategy called Multicolor Combinational Probe Coding 
(MCPC) [103, 104]. To achieve 15-plex detection via MCPC, however, 32 different fluorescently-
labeled probes were synthesized, which escalated the cost of this strategy. Moreover, the probe 
design principle in MCPC capped its multiplexing capacity to 15 when using 4 fluorophores; and 
as spectral overlaps between fluorophores make it difficult to incorporate additional fluorophores, 
MCPC had likely reached its maximum multiplexing capacity. Another strategy, which was coined 
binary-scheme mathematical theory, employed each fluorescence color as a “digit” in the binary 
code and assigned each target sequence with a unique binary code of at least two colors/digits [105]. 
Unfortunately, even when using 4 fluorophores, this strategy still only achieved 4-plex detection. 
Therefore, despite the potential, effective strategies for leveraging combinations of multiple 
fluorophores to achieve multiplexed NAAT remain underdeveloped to date.  
Herein, we describe Ratiometric Fluorescence Coding, our new strategy for expanding the 
multiplexed detection capacity of NAATs by encoding each nucleic acid target with a specific 
fluorescence ratio. Specifically, in Ratiometric Fluorescence Coding, we transform each target into 
a specific DNA template that can hybridize with multiple fluorescently-labeled probes with distinct 
colors at a pre-designed, unique ratio. In doing so, we can specifically detect each target while 
obviating the restriction of spectral overlaps between fluorophores. Moreover, since only the ratios 
of fluorescent probe hybridization sites in DNA templates are designed to vary but the sequences 
of the hybridization sites remain the same, our Ratiometric Fluorescence Coding can utilize the 
same set of fluorescently-labeled probes to detect multiple targets. For demonstrating the concept 
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of Ratiometric Fluorescence Coding, we utilized padlock probe chemistry [106] for probe design 
and coupled with either rolling circle amplification (RCA) or hyperbranched rolling circle 
amplification (HRCA) [107-109] for DNA template generation, which allows hybridization with 
fluorescent-labeled probes. Using our RCA and HRCA assays and only two fluorescently-labeled 
probes, we demonstrate the detection of the gene sequences from up to 6 infectious diseases, 
including 4 sexually transmitted diseases (STDs) and 2 urinary tract infections (UTIs), with distinct 
and highly resolved fluorescence ratios, illustrating that Ratiometric Fluorescence Coding offers 
ready means for expanding the multiplexed detection capacity of NAATs. In addition, we have 
coupled our Ratiometric Fluorescence Coding assay with a droplet-based microfluidics system to 
extend its utility to simultaneously detecting multiple targets in a single reaction, termed Digital 
Ratiometric Fluorescence Coding. For demonstration, we have detected DNA targets from six 
sexually transmitted diseases and demonstrated its potential for further expanding the multiplexing 
capability of our method. 
3.2 Experimental Details 
3.2.1 Materials and Reagents 
All DNA oligonucleotides including synthetic targets, padlock probes, and primers were 
purchased from Integrated DNA Technologies, Inc. (Coralville, IA) and both fluorescently-labeled 
peptide nucleic acid (PNA) probes were purchased from PNA Bio (Newbury Park, CA). Reagents 
for ligation, RCA, and HRCA reactions, including 9°N™ DNA Ligase, 10× 9°N™ DNA Ligase 
Reaction Buffer, Phage T4 Gene-32 Protein, Phage ø29 DNA Polymerase, Exonuclease I (E. coli), 
Exonuclease III (E. coli), 10× Isothermal Reaction Buffer, Bst DNA polymerase, and 10× Bst 
Polymerase Reaction Buffer were purchased from New England BioLabs, Inc. (Ipswich, MA). 
Deoxyribonucleotide triphosphate (dNTP) was purchased from Invitrogen Corp. (Carlsbad, CA). 
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Formamide, sodium chloride (NaCl), EDTA (pH 8.0), Bovine Serum Albumin (BSA), Betaine and 
H2O (PCR grade) were purchased from Sigma-Aldrich Corp. (St. Louis, MO). 
3.2.2 Nucleic Acid Oligonucleotide Sequences 
Padlock probes targeting gene sequences in Proteus mirabilis (PM, 238:275 from 
AF240693) Human immunodeficiency virus 1 (HIV-1, 258:305 from KC966998), Neisseria 
gonorrhoeae (NG, 362:411 from X52364), Chlamydia trachomatis (CT, 50:98 from JX648604), 
Treponema pallidum (TP, 801:846 from KC966998), and Escherichia coli (EC, 189:230 from 
AY447194) were designed in-house. All padlock probe and synthetic target sequences are given in 
Table 3.1. The sequence of the RCA primer is 5'-CTAAAGCTGAGACATGACGAGTC and the 
sequence of the additional primer for performing HRCA is 5'- TCAGAACTCACCTGTTAG. The 
sequences of the red and the green PNA probes are [5’AlexaF647] TCAGAACTCACCTGTTAG 
and [5’AlexaF488] CCCTAACCCTAACCCTAA, respectively. 
For droplet-based Digital Ratiometric Fluorescence Coding assay, another group of six 
padlock probes Padlock probes targeting gene sequences in Microplasma genitalium (MG, 
1420:1473 from M31431), Herpes Simplex Virus (HSV, 1426:1473 from K01760), Neisseria 
gonorrhoeae (NG, 362:411 from X52364), Human immunodeficiency virus (HIV, 258:305 from 
KC966998), Treponema pallidum (TP, 801:846 from KC966998) and Chlamydia trachomatis (CT, 
50:99 from JX648604) were designed in-house. All padlock probe and synthetic target sequences 
are given in Table 3.2. The sequence of the HRCA primers are 5'- 
TTCGTTCGTTTATCGGGTATTT TAGT and 5'- CGATACCGAACCTAAAACTAATC. The 
sequences of the red and the green MBs are /5Alex555/cCGaCtCaAcCGG/3BHQ_2/ and 
/5Alexa488/tCCgAgCgTaGGA/3BHQ_1/, respectively (Locked Nucleic Acid (LNA) bases are 
denoted in lower case). All oligonucleotides were purchased from Integrated DNA Technologies, 
Inc. (Coralville, IA). 
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3.2.3 Padlock Probe Hybridization and Ligation 
Our Ratiometric Fluorescence Coding assays began with padlock probe hybridization and 
ligation, which were achieved in a single-tube reaction. The 25-µL reaction mixture contained 45 
nM of each linear padlock probe, synthetic DNA targets (at different concentrations), 0.4 Units/µL 
9°N™ DNA Ligase, and 1× 9N DNA Ligase Reaction Buffer (10 mM Tris-HCl, 600 µM ATP, 2.5 
mM MgCl2, 2.5 mM Dithiothreitol, 0.1% Triton X-100, pH 7.5 at 25°C). Padlock probe 
hybridization and ligation was performed at 60 °C for 1 hour. For subsequent HRCA reaction, only 
100 pM of each padlock probe were ligated in the presence of synthetic DNA targets or pathogen 
genomic DNA to reduce non-specific amplification and improve signal-to-noise-ratio. 
The padlock probe hybridization and ligation reactions for Digital Ratiometric 
Fluorescence Coding assay was performed in a 8-µL reaction mixture containing 50 pM of each 
linear padlock probe, synthetic DNA targets at different concentrations, 1.5 Units/µL 9°N™ DNA 
Ligase, and 1× 9N DNA Ligase Reaction Buffer. Padlock probe hybridization and ligation was 
performed at 55 °C for 1 hour. The 8-µL ligation product was then treated with 10 units of 
Exonuclease I and 50 units of Exonuclease III at 37 °C for 2 hour to remove extra linear padlock 
probes that were not circularized, followed by a brief incubation at 85 °C for 10 minutes to 
inactivate the enzymes. 
3.2.4 RCA and HRCA Reactions 
RCA or HRCA were performed immediately after ligation of padlock probes to generate 
DNA templates that allow hybridization with fluorescently-labeled probes. For RCA, 2 μL of the 
ligation product was mixed with 800 nM rolling-circle primer, 400 μM dNTPs, 10 U/µL Phage ø29 
DNA polymerase, and 1× Isothermal Reaction Buffer (50 mM Tris•HCl (pH 7.5), 10 mM MgCl2, 
200 μg/mL acetylated BSA) to a final volume of 25 µL. Of note, due to its high strand-displacing 
activity, Phage ø29 DNA polymerase was added last to the reaction mixture, which was then 
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immediately incubated at 31 °C for 1 hour to perform RCA, followed by 70 °C for 10 minutes to 
inactivate the polymerase and stop the reaction.  
For HRCA, 25 μL of the ligation product was first treated with 10 units of Exonuclease I 
and 50 units of Exonuclease III at 37 °C for 1 hour to remove extra linear padlock probes that were 
not circularized, followed by a brief incubation at 85 °C for 10 minutes to inactivate the enzymes. 
Then 4 µL of this enzyme-treated ligation product was mixed with 400 nM of each of the two 
rolling-circle primers, 400 µM dNTPs, 40 ng/ml Phage T4 Gene-32 Protein, 10 U/µL Bst DNA 
polymerase, and 1× Bst Polymerase Reaction Buffer (20 mM Tris•HCl (pH 8.8), 10 mM KCl, 2.7 
mM MgSO4, 5% v/v DMSO, 0.1% Triton × 100) to a final volume of 25 µL. The reaction mixture 
was incubated at 60 °C for 1 hour to perform HRCA, followed by 85 °C for 10 minutes to inactivate 
the polymerase and stop the reaction. 
3.2.5 Fluorescent PNA Hybridization and Detection 
10 µL RCA or HRCA product was mixed with 500 nM AlexaF488-labeled PNA probe and 
500 nM AlexaF647-labeled PNA probe in a PNA hybridization buffer (40% Formamide, 10 mM 
NaCl, and 50 mM Tris•HCl (pH 8)), heated at 85 °C for 5 minutes, and then incubated at room 
temperature in the dark for 2 hours to allow hybridization. Non-hybridized, excess fluorescent PNA 
probes were removed by using S400-HR microspin columns (GE Healthcare). Each purified sample 
was pipetted into a well of a 384-well plate (Corning Inc.) and read out on a Typhoon image scanner 
(GE Healthcare) in both the red channel (peak excitation at 633 nm with 670 nm band-pass emission 
filter) and the green channel (peak excitation at 488 nm with 526 nm short-pass emission filter) at 
a photomultiplier tube (PMT) voltage of either 600 V or 650 V. Of note, for each experiment, the 
PMT voltage was kept the same between the red channel and the green channel (i.e., both at 600 V 
or both at 650 V). Between experiments, however, the PMT voltage was sometimes adjusted 
between either at 600 V or at 650 V. 
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3.2.6 Microfluidic Chip Fabrication 
Our microfluidic device was featured with a 10-mm flow focusing junction. The mold for 
our device was first prepared via soft lithography. For chip fabrication, the mold was initially 
silanized with chlorotrimethylsilane (Sigma-Aldrich, St. Louis, MO, USA) for 15 min before 
pouring PDMS (SYLGARD 184 Silicone Elastomer Kit, Dow Corning, Midland, MI, USA) onto 
the mold. After curing for 1 hour at 80°C, the 5mm PDMS slab was peeled off, on which the holes 
were punched using a sharpened needle (20 gauge; McMaster-Carr, Elmhurst, IL, USA) as inlets 
and outlets. Then the PDMS slab was cleaned by a thorough hole cleaning using IPA to eliminate 
the PDMS residues. The cleaned PDMS slab was bonded onto a glass slide using oxygen plasma 
treatment before hydrophobic treatment with Aquapel. 
3.2.7 Droplet Generation and Amplification 
For our Digital Ratiometric Fluorescence Coding, 4 µL of enzyme-treated ligation product 
was mixed with 400 nM of each of the two HRCA primers, 200 nM of each of the two MBs, 400 
µM dNTPs, 0.25 mg/mL BSA, 800 nM Betaine, 40 ng/ml Phage T4 Gene-32 Protein, 0.32 U/µL 
Bst DNA polymerase, and 1× Bst Polymerase Reaction Buffer (NEB) to a final volume of 50 µL. 
The 50-µL HRCA reaction mixture was kept in ice before loaded for droplet generation. 
We used microfluidic device to encapsulate the circularized padlock probes into picoliter-
volume droplets for digital HRCA reaction and ratiometric fluorescence coding. Basically, the 
circularized probe encapsulation in droplets follows the Poisson distribution. In order to separate 
single circularized probe and achieve multiplexing detection, the circularized padlock probes were 
appropriately diluted to make sure that most of droplets encapsulate either zero or single copy probe 
for HRCA amplification so that the produced color ratio was not messed up by each other. 
Specifically, the microfluidic device employed a 10-µm flow-focusing junction to generate 
3-pL droplets with one inlet for droplet generation oil (008-FluoroSurfactant dissolved HFE 7500, 
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RAN Biotechnologies, Inc., Beverly, MA) and two inlets for amplification mixture. To generate 
droplets, the 50-µL HRCA reaction mixture was loaded into two Tygon tubings which connected 
to a Hamilton 1000 glass syringe with FC40 oil as a displacement fluid and then injected into the 
microfluidic device using a syringe pump (Harvard Apparatus, Holliston, MA) at a 50 µL/h flow 
rate. The droplet generation oil was driven at 300 µL/h by another separate syringe pump to shear 
the HRCA mixture into droplets at the 10-µm flow-focusing junction. Millions of droplets can be 
generated within 15 mins and they were then collected in a tube with extra oil removed to pack 
them. The droplets containing HRCA reaction mixture were incubated at 60 °C for 2 hours for 
digital HRCA amplification, followed by 95 °C for 5 minutes to inactivate the polymerase and 
denature double-strand oligonucleotides for MB hybridization. The green and red MBs then bind 
with the denatured amplified targets at 37 ° for 20 min as the last step before detection. 
3.2.8 Droplet Fluorescence Measurement 
To interrogate the fluorescence of single picoliter-volume droplets after MB binding with 
the amplified targets, a custom-built confocal microscope detection system with an adjustable stage 
was used for fluorescence detection. First, the amplified droplets were loaded into Tygon tubings 
with caution to avoid droplet merging and reinjected into the microfluidic device with a 15-µL/h 
flow rate. To achieve single droplet detection, the detection module of our device used a 10-µm 
constriction channel to get single droplet flow. Then two laser sources, 488 nm (2 mW) and 545 
nm (6 mW) respectively, were focused in the middle of the 10-µm-constriction channel to excite 
the fluorophores. The red and green fluorescence intensities of each droplet flowing through the 
channel were measured with APDs with a 0.1 ms sampling time and recorded by a custom-written 
LabView program for subsequent analysis. 
3.2.9 Data Analysis 
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For our Ratiometric Fluorescence Coding assay performed in tubes, red and green 
fluorescence intensities of each sample measured by the Typhoon image scanner were quantified 
by ImageQuantTL software (GE Healthcare). The R/G ratio was calculated via dividing the red 
fluorescence intensity by the green fluorescence intensity. 
For our Digital Ratiometric Fluorescence Coding assay, the droplet fluorescence trace was 
loaded into MATLAB for data processing. First, droplets with appropriate size were selected to 
rule out any droplet merging or shearing during operation. Then a double gaussian fitting was used 
to fit the fluorescence intensity of the selected droplets to get the mean and standard deviation for 
empty droplets (‘negative’ droplets) which were used to set the threshold for selecting droplets with 
circularized padlock probe (‘positive’ droplets). The threshold for red channel was set to be equal 
to negative mean plus 9 folds of negative standard deviation to get rid of false positive signal.  The 
threshold for green channel was set to be 225 since we noticed that there was some low non-specific 
amplification signal in green channel and they were typically smaller than 225. Droplets with 
fluorescence signal above the threshold of either green or red channel were considered to be 
positive. In order to calculate the color ratios for these positive droplets, we subtracted the negative 
mean from both channels to get the true signals and used the ratio between the true signals to 
characterize and identify different targets. 
3.3 Design of Padlock Probes for Ratiometric Fluorescence Coding 
Our Ratiometric Fluorescence Coding encodes each target of interest with a specific 
fluorescence color ratio. This is achieved by transforming each target to a specific DNA template 
sequence with a pre-designed and unique ratio of binding sites for multiple fluorescently-labeled 
probes with distinct colors. As such, upon hybridization with fluorescent probes, the template-probe 
complex displays the specific ratiometric fluorescence code whose intensity of each fluorescence 
color can be measured to decode and identify the target (Figure 3.1A). Importantly, in Ratiometric 
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Fluorescence Coding, the number of maximum target-specific fluorescence ratios (i.e., the 
multiplexing capacity) for a given number of fluorescence colors is governed by a polynomial 
relationship with the number of fluorescent probe binding sites (S) that can be designed on a DNA 
template. In the case of 2 fluorescence colors, the maximum achievable fluorescence ratios are 
(𝑆2+4𝑆−1)4  for an odd number of S and (𝑆2+3𝑆+3)4  for an even number of S, respectively. For example, 
with only a red fluorophore (e.g., AlexaF647) and a green fluorophore (e.g., AlexaF488), we can 
achieve up to 7 fluorescence ratios if we design 4 fluorescent probe binding sites (S = 4) on each 
DNA template, and up to 11 ratios if we design 5 binding sites (S = 5) on each DNA template. 
Moreover, in Ratiometric Fluorescence Coding, only the numbers of fluorescence probe binding 
sites in the DNA templates are designed to vary but the sequences of the fluorescence probe binding 
sites remain the same. As such, the same fluorescently-labeled probes can be used for detecting 
multiple targets. These features allow our Ratiometric Fluorescence Coding to expand the 
multiplexing capacity when compared with the traditional one-color-one-target approach and 
multi-fluorophore strategies without requiring a large number of fluorescently-labeled probes. 
Padlock probe chemistry provides an effective means for achieving Ratiometric 
Fluorescence Coding due to its flexibility for probe design. In this work, we design each padlock 
probe to contain a target-specific hybridization region, a uniquely pre-designed ratio of binding 
sites for the red and the green fluorescent probes, and general primer sites (Figure 3.1B). In the 
presence of its specific DNA target, the initially linear padlock probe is first hybridized to the target 
and then ligated to become a circular probe, from which DNA templates can be generated via 
various amplification techniques to amplify the number of fluorescent probe binding sites at the 
pre-designed fluorescent probe ratio encoded in each padlock probe [107, 108, 110]. Following this 
design principle, we designed six circularizable padlock probes to detect 6 common infectious 
diseases (4 STDs and 2 UTIs) in this work. The target-specific regions of these 6 padlock probes 
target conserved sequences from Proteus mirabilis (PM), Human immunodeficiency virus 1 (HIV-
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1), Neisseria gonorrhoeae (NR), Chlamydia trachomatis (CT), Treponema pallidum (TP) and 
Escherichia coli (EC). Moreover, we incorporated the binding sites for the red and the green 
fluorescent probes at specific red to green (R/G) ratios into these padlock probes: 0:1 for PM, 1:2 
for HIV-1, 1:1 for NR, 2:1 for CT, 3:1 for TP and 1:0 for EC, respectively (Figure 3.1C).  
We have also coupled padlock probe chemistry with molecular amplification techniques, 
such as RCA and HRCA, to amplify the fluorescence signals in ratiometric fluorescence coding. 
More specifically, we begin by challenging the infectious disease-related DNA targets to the 
mixture of our six target-specific, linear padlock probes. In the presence of a DNA target, the 
corresponding linear padlock probe is hybridized and ligated to form a closed padlock probe. Then 
RCA reaction amplifies along the circular padlock probe to generate DNA templates with hundreds 
of tandem repeats that serve as hybridization sites for fluorescent probes. In this work, we employed 
AlexaF488- and AlexaF647- peptide nucleic acid (PNA) as the hybridization probes, because its 
electro-neutral polypeptide backbones enable high hybridization efficiency with the DNA 
templates [111, 112]. In addition, the dissociation rate of PNA/DNA hybrid is significantly slower 
than that of DNA duplexes, thus allowing the removal of non-hybridized, excess PNA from the 
reaction without reducing the fluorescence signals of the template-probe complexes due to 
dissociation of hybridized fluorescent probes. After fluorescent PNA probe hybridization and 
purification, the red and the green fluorescence intensities of the template-probe complexes are 
measured, and the resultant R/G fluorescence ratio is used to identify the DNA target (Figure 3.1D). 
3.4 Ratiometric Fluorescence Detection with RCA 
Using our RCA-based ratiometric fluorescence coding assay, we first demonstrate the 
detection of six infectious disease-related gene sequences with distinct fluorescence ratios. To do 
so, we used six synthetic oligonucleotides derived from conserved gene sequences of PM, HIV-1, 
NG, CT, TP and EC as the targets, challenged each of them to our mix of six padlock probes, and 
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measured the red and the green fluorescence intensities of each sample at the end of the RCA 
reaction and probe hybridization. Fluorescent images of the six samples reveal that the six targets 
indeed yielded fluorescence ratios that were noticeably different from each other (Figure 3.2A). 
Moreover, the measured R/G ratio of each target closely matched its designed R/G ratio. For 
example, for the PM sample, the corresponding padlock probe of which is inserted with only green 
fluorescent probe binding sites, we observed only green fluorescence and no red fluorescence was 
detected, resulting in a measured R/G ratio of 0. While for the HIV-1 sample we observed weak 
red fluorescence and strong green fluorescence and measured a R/G ratio of ~0.5. In contrast, for 
the TP sample, we observed strong red fluorescence and weak green fluorescence, and measured a 
R/G ratio of ~3.0. Whereas for the EC sample, the padlock probe of which contains only red 
fluorescent probe sequence, we only observed fluorescence in the red channel and thus the R/G 
ratio was measured to be infinity.  These fluorescence detection results clearly indicate that our 
RCA-based ratiometric fluorescence coding assay can achieve multiplexed detection of nucleic 
acid targets based on distinct R/G ratios. 
Our RCA-based ratiometric assay detects the six infectious disease-related gene sequences 
with high reproducibility. Here, we replicated our assay for PM, HIV-1, NG, CT, TP and EC 
synthetic targets in four separate experiments, and plotted the average R/G ratios with error bars 
based on the four independent measurements (Figure 3.2B). The close match between the 
measured R/G ratios and the pre-designed R/G ratios provides strong support for the design 
principle of ratiometric fluorescence coding. In addition, the small error bars of measured ratios 
indicate that each target-specific ratio is indeed significantly different from each other and that our 
assay is highly reproducible. Taken together, these results also suggest that additional R/G ratios 
can be incorporated into our RCA-based assay by inserting additional binding sites in the padlock 
probes, which can expand the multiplexed detection capacity of the assay. 
3.5 Ratiometric Fluorescence Detection with HRCA 
76 
 
Toward improving the sensitivity of multiplexed detection via our ratiometric fluorescence 
coding method, we show the compatibility between our method and HRCA. Compared with the 
linear amplification mechanism in RCA, HRCA employs a second primer to achieve exponential 
amplification of double-stranded DNA (dsDNA) templates (Figure 3.3) for fluorescent probes [113, 
114]. Our PNA probe plays a critical role here, because strong binding affinity between PNA and 
DNA ensures our PNA probes can hybridize to the DNA templates even in the presence of 
complementary DNA strands. To verify the HRCA-based assay, we mixed our four padlock probes 
with each of the HIV-1, NR, CT and TP synthetic targets and detected the red and the green 
fluorescence intensities of each sample at the end of the HRCA reaction and probe hybridization. 
Similar to the results from RCA reactions, fluorescent images of these four HRCA samples also 
show fluorescence ratios that were noticeably distinct (Figure 3.4A). For example, we again 
observed relatively weak red fluorescence and strong green fluorescence for the HIV-1 sample, 
yielding a measured R/G ratio of ~0.8. On the other hand, strong red fluorescence and weak green 
fluorescence could be observed from the CT sample and the TP sample, with measured R/G ratios 
of ~3.4 and ~5.2, respectively. We similarly replicated the experiments four times and plotted the 
measured R/G ratios with errors bars (Figure 3.4B). The results indicated high reproducibility of 
our HRCA-based assay for detecting STD-related gene sequences based on distinct R/G 
fluorescence ratios. 
Having verified robust multiplex detection through both our HRCA-based and RCA-based 
ratiometric fluorescence coding assays, we note that the measured R/G ratio for each HRCA sample 
was higher than that for its RCA counterpart. The difference in measured R/G ratios may be caused 
by the difference in self-quenching of neighboring Alexa Fluro 647 molecules between the HRCA 
and the RCA samples [115, 116]. Specifically, in RCA, the template-probe complex that is formed 
when thousands of probes hybridize onto long single-stranded DNA templates could fold into a 
spherical conformation in solution [117, 118]. This conformation confines the Alexa Fluro 647 
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molecules, and their proximity causes them to quench each other, thus reducing the red 
fluorescence intensity in RCA samples. In contrast, double strand DNA templates produced from 
HRCA were only hundreds of base pairs in length (Figure 3.3), which allowed much fewer 
fluorescent probes to hybridize onto each template and reduced the potential for self-quenching of 
neighboring Alexa Fluro 647 molecules. As a result, the intensities of red fluorescence in HRCA 
samples were elevated, resulting in higher R/G ratios. 
3.6 Sensitivity of Ratiometric Fluorescence Coding Assay 
Finally, we examine the sensitivity of our HRCA-based ratiometric fluorescence coding 
assay and its ability to detect genomic DNA. Here, we titrated our four STD synthetic targets to 1 
pmol, 1 fmol, 1 amol to 1 zmol, tested them with our HRCA-based assay, and measured their red 
and green fluorescence intensities. For each target, as the input concentration lowered, both the red 
and the green fluorescence intensities expectedly reduced as a result of lower concentration of 
dsDNA templates generated from lower concentration of target, though all four targets were still 
detected at 1 zmol (Figure 3.5A). More importantly, for each target, even as the input concentration 
decreased by 9 orders of magnitude, the measured R/G ratios remained fairly consistent (Figure 
3.5B). For example, the R/G rations for NR synthetic targets remained at ~2 for the 4 input target 
concentrations. The consistency of measured R/G ratios for the 4 targets across a wide range of 
input concentrations further illustrates the robustness of our ratiometric fluorescence coding 
method. Finally, we also used our HRCA-based assay to detect 200 ng and 2 ng NR genomic DNA 
(extracted from Neisseria gonorrhoeae Strain FA1090, ATCC). We observed strong red and green 
fluorescence in the sample with 200 ng NR genomic DNA sample and noticeably weaker 
fluorescence in the sample with 2 ng NR genomic DNA (Figure 3.5C, left). Moreover, the 
measured R/G ratios in both genomic DNA samples were comparable to that of the NR synthetic 
target (Figure 3.5C, right). These results therefore suggest that our HRCA-based ratiometric 
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fluorescence coding assay can also detect STD genomic DNA based on its pre-designed 
fluorescence ratio. 
3.7 Digital Ratiometric Fluorescence Coding 
In previous chapters, we have demonstrated our Ratiometric Fluorescence Coding method 
for the detection of DNA targets from six infectious diseases using only two distinctly colored 
fluorescent probes However, the previous interaction of this approach is limited to identifying only 
one single pathogen among a number of suspected candidates, and its performance may be 
compromised by coinfections in clinical samples. Herein we have improved its utility for 
multiplexed nucleic acid detection by coupling Ratiometric Fluorescence Coding assay with a 
droplet-based microfluidic system. By encapsulating single copy of circularized padlock probe into 
droplet for amplification and measuring R/G fluorescence ratio of each droplet after fluorescent 
labeling, this approach allows  simultaneously detecting multiple targets in a single reaction, termed 
Digital Ratiometric Fluorescence Coding. 
Similar to our Ratiometric Fluorescence Coding assay described in Chapter 3.3, the 
Digital Ratiometric Fluorescence Coding also utilizes padlock probe chemistry coupled with 
HRCA to transform each target into a specific DNA template that allows hybridization of red and 
green molecular beacons (MBs) at a pre-designed ratio in single droplet (Figure 3.6A). Similar to 
previous work, we design each padlock probe to contain a target-specific hybridization region, a 
unique ratio of binding sites for red and green MBs and general primer sites. In the presence of a 
DNA target, the corresponding linear padlock probe is ligated to form a circular probe, which is 
then capsulated into a ~3pL droplet for subsequent HRCA. Like digital PCR […], the circular 
probes are distributed into these droplets following the Poisson distribution, where there are some 
droplets that have no circular probe, and others that have one or more copies of circular padlock 
probe encapsulated. In our work, the mixture for amplification reaction were appropriately diluted 
79 
 
to make sure that most of droplets encapsulate either zero or single copy of circular probe. A PDMS 
microfluidic device (Figure 3.7) is fabricated for droplet generation and measurement. Droplets 
are generated through a 10 µm flow-focusing junction on the device and then incubated at 60 °C 
for 2 hours. Within those droplets containing circular probes, HRCA amplifies along the circular 
probe to generate DNA templates with hundreds of tandem repeats that serve as hybridization sites 
for MBs. After MB hybridization, red and green fluorescence intensities of each droplet are 
measured through a custom confocal microscope system (Figure 3.8), and the resultant red to green 
(R/G) fluorescence ratio is used to identify the DNA target. After MB hybridization, droplets were 
observed using a fluorescence microscope under white light, red channel and green channel (Figure 
3.6B). The droplets presenting fluorescence signals indicated that a single copy of circular padlock 
probe was capsulated into the droplet and amplified via HRCA, while no fluorescence signal was 
observed in the droplets without circular probes. 
For a sample with multiple targets, the hybridization and ligation reaction generate multiple 
circular probes with distinct pre-designed MB ratios encode in initially linear padlock probes. After 
droplet generation, single copy of circular probes with distinct pre-designed MB ratios are 
encapsulated into different droplets. After amplification reaction and MB hybridization, theses 
droplets containing different circular probes, from which DNA templates with distinct 
hybridization sites for MBs are generated via HRCA, present distinct R/G fluorescence colors that 
can be used to identify the DNA targets in the initial sample. Using our Digital Ratiometric 
Fluorescence Coding method, we demonstrate the multiplexed detection of gene sequences from 
up to 6 STDs, with distinct and highly resolved fluorescence ratios, indicating that our method 
offers ready means for expanding the multiplexed detection capacity of NAATs. 
3.8 Digital Ratiometric Fluorescence Detection of Single Target 
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In this work, we designed six circularizable padlock probes to detect 6 common STDs. The 
target-specific regions of these 6 padlock probes target conserved sequences from Microplasma 
genitalium (MG), Herpes simplex virus (HSV), Neisseria gonorrhoeae (NR), Human 
immunodeficiency virus (HIV), Treponema pallidum (TP) and Chlamydia trachomatis (CT). 
Moreover, we incorporated the binding sites for the red and the green fluorescent probes at specific 
red to green (R/G) ratios into these padlock probes: 0:1 for MG, 1:4 for HSV, 1:1 for NG, 2:1 for 
HIV-1, 4:1 for TP and 1:0 for CT, respectively. Using our Digital Ratiometric Fluorescence Coding 
method, we demonstrate the multiplexed detection of gene sequences from the six STDs with 
distinct fluorescence ratios. 
Using our Digital Ratiometric Fluorescence Coding method, we first demonstrate the 
detection of six STD-related gene sequences with distinct fluorescence ratios. To do so, we used 
six synthetic oligonucleotides derived from conserved gene sequences of MG, HSV, NG, HIV, TP 
and CT as the targets, challenged each of them to our mix of six padlock probes, and measured the 
red and the green fluorescence intensities of droplets from each sample. After fluorescence 
measurement on the confocal microscope system, samples with different DNA targets indeed 
yielded R/G fluorescence ratios that were noticeably distinct from each other (Figure 3.9). For 
example, for the MG sample, the corresponding padlock probe of which is inserted with only green 
MB binding sites, we observed only green fluorescence and no red fluorescence was detected. 
While for the NG sample with pre-designed R/G fluorescence ratio of 1:1, the detected peak heights 
of red fluorescence in the droplets are close to those of green fluorescence. In contrast, for the HIV-
1 sample, the padlock probe of which is designed to have R/G fluorescence ratio of 2:1, we 
observed strong red fluorescence and weak green fluorescence in the measured droplets, while for 
the TP sample with pre-designed R/G ratio of 4:1, even stronger red fluorescence signal and weaker 
green fluorescence signal were observed. Whereas for the CT sample, the padlock probe of which 
contains only red MB sequence, we only observed fluorescence signal in the red channel and no 
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green fluorescence signal. These fluorescence detection results clearly indicate that our Digital 
Ratiometric Fluorescence Coding assay can identify the nucleic acid targets based on distinct R/G 
ratios.  Moreover, the scatter plot for red and green fluorescence intensities in each sample revealed 
that the six target-specific R/G fluorescence ratios can be unambiguously separated (Figure 3.10).  
We also calculated average measured R/G fluorescence ratios and standard deviation of 
R/G ratios from over thousands of droplets in each sample (Figure 3.11A). The results also showed 
that six measured fluorescence ratios were noticeably distinct and indicated our Digital Ratiometric 
Fluorescence Coding assay for detecting STD-related gene sequences based on distinct R/G 
fluorescence ratios. Moreover, the strong linearity between the measured R/G ratios and the pre-
designed R/G ratios (slope= 1.6643 and R2 = 0.9973, Figure 3.11B) provides strong support for 
the design principle of our Ratiometric Fluorescence Coding. We note that the average measured 
R/G fluorescence ratio for each sample was higher than that for its pre-designed R/G ratios. Similar 
to the discussion about how self-quenching of neighboring Alexa Fluro 647 molecules in Chapter 
3.5, though the R/G ratios are different, we think it shouldn’t affect the demonstration of our 
Ratiometric Fluorescence Coding concept. Based on the experimental protocol of our assay, there 
are six key factors that affects the measured R/G ratios: 1) pre-designed ratios of red and green 
fluorescent probe/MB sequences on padlock probe, 2) fluorescence quantum yield, 3) hybridization 
efficiency of fluorescent probe/MB, 4) fluorophore self-quenching, 5) excitation laser power, and 
6) fluorescence measurement. As we know, pre-designed R/G ratio on padlock is the main factor 
that leads to distinct measured R/G ratios. We also have known that the fluorescence quantum 
yields for these two dyes, AlexaF647 and AlexaF488, are 0.33 and 0.92 respectively, and two laser 
powers on the custom confocal microscope system are not the same in our experiments. However, 
there are three other main factors, probe hybridization efficiency, fluorophore self-quenching and 
instrument detection efficiency, which are not identical for these two dyes, but cannot be quantified 
in the experiments. The existence of other unmeasurable factors, together with known or 
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measurable factors, may result in the difference between measured R/G fluorescence ratios and 
pre-designed R/G ratios. Moreover, the essence of our Ratiometric Fluorescence Coding concept 
is to encode each nucleic acid target with a specific fluorescence ratio, thus the measured R/G ratios 
are not necessary to be the same as pre-designed ratios once the measured ratios are clearly 
differentiable and robustly reproducible for the identification of each nucleic acid target, which has 
been demonstrated using six STD target sequences. 
3.9 Digital Ratiometric Fluorescence Detection of Multiple Targets Simultaneously 
We have demonstrated our Digital Ratiometric Fluorescence Coding method for 
multiplexed detection of different STD-related gene sequences in a single reaction. First, we mixed 
both NG and HIV synthetic targets with our six padlock probes for hybridization and ligation in a 
single reaction. After droplet generation and amplification, we measured the red and green 
fluorescence intensities of each droplet. The resultant scatter plot for red and green fluorescence 
intensities present two populations that are unambiguously separated (Figure 3.12A). Moreover, 
the average measured R/G ratios of NG population (Figure 3.12A, yellow dots) is around 1.6, close 
to the measured R/G ratio resultant from the sample with NG target only (Figure 3.11A), while the 
average measured R/G ratios of HIV population (Figure 3.12A, yellow dots) is ~3.2, close to the 
R/G ratio of single target HIV sample (Figure 3.11A). 
In addition, we mixed four different STD synthetic targets, MG, CT, NG and HIV, in a 
single reaction and tested using our Digital Ratiometric Fluorescence Coding assay. In the resultant 
scatter plot for red and green fluorescence intensities measured, four distinct population are clearly 
separated (Figure 3.12B). More specifically, there is one population of droplets with strong green 
fluorescence signals and nearly no red fluorescence signals, which demonstrates the presence of 
MG targets, the padlock probe of which is inserted with only green MB binding sites, we observed 
only green fluorescence and no red fluorescence was detected. In contrast, another droplet 
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population with no green fluorescence and strong red fluorescence represents the CT target, of 
which the padlock probe has only red MB binding sites. The other two populations look the same 
as the two distinct populations we observed in the sample with the mixture of NG and HIV targets 
(Figure 3.12A). For further demonstration, we mixed all six STD targets and the resultant scatter 
plot for red and green fluorescence intensities presents six well-separated populations (Figure 
3.12C). Besides the four populations observed in Figure 3.12B, there is one population showing 
up between the two populations presenting MG and NG (Figure 3.12C, cyan), which demonstrates 
the presence of HSV target with pre-designed R/G ratio of 1:4. While another additional population 
between HIV and CT represents the existence of TP, of which the padlock probe has pre-designed 
ratio of 4:1 (Figure 3.12C, magenta). These results have demonstrated our Digital Ratiometric 
Fluorescence Coding method for multiplexed detection of nucleic acid targets based on distinct 
R/G fluorescence ratios. 
3.9 Conclusion 
In this chapter, we have developed a new ratiometric fluorescence coding concept that can 
be employed to significantly expand multiplexing capacity of NAAT by assigning a specific 
fluorescence color ratio for coding each target. Unlike common one-color-one-target scheme, we 
produce a target-specific DNA template with a pre-designed ratio of binding sites for distinctly 
colored fluorescent probes. Our concept has been validated using padlock probe chemistry coupled 
with RCA or HRCA reactions. With our custom-designed padlock probes targeting infectious 
disease-related genes, we have demonstrated our ratiometric fluorescence coding method for 
multiplexed detection of 6 nucleic acid targets using only two distinctly colored fluorescent probes. 
In addition, our HRCA-based assay has been utilized to detect genomic DNA from a specific STD. 
Furthermore, we have coupled the assay with a droplet-based microfluidic system to extend 
its utility to simultaneously detecting multiple targets in a single reaction. With our custom-
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designed padlock probes targeting STD-related genes, we have demonstrated our Digital 
Ratiometric Fluorescence Coding method for multiplexed detection of 6 nucleic acid targets using 
only two distinctly colored molecular beacons, as well as its potential for further expanding the 
multiplexing capacity. 
There are several areas to improve our method for highly multiplex and sensitive detection 
of nucleic acids. First, the multiplexing capacity of our method can be readily expanded by using 
more fluorescence colors and designing more fluorescent probe binding sites. For example, using 
3 colors and 5 binding sites (S=5), the maximum number of ratio can reach 40 (Table 3.3). Since 
the commercially available phosphorylated single-stranded DNA is limited to 200 bp from 
Integrated DNA Technologies, Inc. (Coralville, IA), decreasing the length of fluorescent probes 
can be an alternative approach to provide more available probe binding sites on a padlock probe. 
Especially using high affinity DNA analogues, such as PNA, as fluorescent probes, the probe length 
can be decreased to 12-mer or even shorter [119, 120], which will allow more than 10 binding sites 
on a single padlock probe. In addition, we can also perform multiplexed detection of nucleic acid 
by coupling our Ratiometric Fluorescence Coding concept with single molecule detection method 
[121, 122]. The molecule-by-molecule measurement scheme in single molecule detection system 
can measure fluorescently-labeled template-probe complexes one at a time in both red and green 
channel simultaneously, thus allows differentiation of template-probe complexes from different 
targets based on their distinct R/G ratios, which can be utilized for simultaneous detection of 
multiple targets in a single reaction. In addition to RCA and HRCA reactions, we also envision that 
strategies for coupling our Ratiometric Fluorescence Coding concept with other nucleic acid 
amplification techniques such as LCR and PCR can be readily developed. Therefore, given the 
good performance of our ratiometric fluorescence coding method and the means to improve it, we 
believe our method has the potential to perform large-scale multiplexed detection of nucleic acids 








Figure 3.1. Overview of Ratiomatric Fluorescence Coding for multiplexed nucleic acid 
detection 
(A) Our ratiometric fluorescence coding concept utilizes a combination of fluorophore colors and 
their fluorescence intensity levels to achieve multiplexed detection. For example, upon 
hybridization of fluorescent probes with two colors (red and green) onto a single DNA template 
with a specific ratio, the template-probe complex can be decoded by resolving the intensity level 
of each color and display the specific red to green (R/G) fluorescence ratio.  (B) The internal part 
of our padlock probe consists of one or two general primer sequences common for all the padlock 
probes and several red and green fluorescent probe sequences, which have a unique R/G ratio for 
each padlock probe. In the presence of corresponding target, padlock probe is ligated to a closed 
circle for subsequent amplification. (C) Six padlock probes with different R/G ratios were designed 
for infectious disease detection. Six circularizable padlock probes encoded as R/G ratio of 0:1, 1:2, 
1:1, 2:1, 3:1 and 1:0 are designed for targeting gene sequences in Proteus mirabilis (PM), Human 
immunodeficiency virus 1 (HIV-1), Neisseria gonorrhoeae (NR), Chlamydia trachomatis (CT), 
Treponema pallidum (TP), and Escherichia coli (EC) respectively. (D) RCA-based ratiometric 
fluorescence assay starts with the mixture of our six target-specific padlock probes and infectious 
disease-related DNA target. When binding to a specific target, the phosphorylated 5' end and the 3' 
end of the padlock probe are brought into proximity that leads to formation of a circularized probe 
via ligation. Subsequently, RCA reaction is performed to generate long ssDNA with thousands of 
tandem repeats complementary to the padlock probe sequences, serving as binding sites for 
fluorophores-labeled PNA probes. Upon hybridization with PNA-AF647 (red) and PNA-AF488 
(green), the fluorophores-labeled amplification products are scanned in both green and red channels 
and the measured R/G fluorescence ratios can be used to identify DNA targets in the initial input. 








Figure 3.2. RCA-based ratiometric fluorescence detection of six gene sequences 
(A) RCA-based ratiometric fluorescence coding assay was validated via detecting six infectious 
disease-related genes. With PM, HIV-1, NR, CT, TP, EC synthetic targets and H2O control, the 
resultant fluorophores-labeled RCA products were scanned under both red (top row) and green 
(bottom row) channels. From left to right in each channel, the fluorescent spots represent 
fluorophores-labeled RCA products resultant from PM, HIV-1, NR, CT, TP, EC synthetic targets 
and H2O control, respectively. Moreover, measured R/G ratio for each sample is close to the pre-
designed ratio. The spots of fluorophores-labeled PM amplification products present fluorescence 
only in green channel with a measured R/G ratio of 0. The spots of HIV-1 sample show weak 
fluorescence in red channel and strong fluorescence in green channel with a measured R/G ratio of 
0.48. The spots of NG sample show nearly equivalent fluorescence intensities in red and green 
channel with a measured R/G ratio of 1.20.  In contrast, the spots of CT and TP samples show 
strong fluorescence in red channel and weak fluorescence in green channel with measured R/G 
ratios of 2.21 and 3.06 respectively. And the spots of EC sample show fluorescence only in the red 
channel with a measured R/G ratio of ∞. The spot of H2O control sample shows no fluorescence 
signal in either red or green channel. (B) Our assay was replicated in four independent experiments 
for detecting the six infectious disease-related synthetic targets. The small error bars of measured 
R/G ratios indicate a robust reproducibility. Adapted with permission from [123]. Copyright 2018 







Figure 3.3. Gel image of HRCA products 
Agarose Gel electrophoresis result of HRCA products of TP, CT, NG and HIV sample. Adapted 













Figure 3.4. HRCA-based ratiometric fluorescence detection of four gene sequences 
(A) HRCA-based ratiometric fluorescence coding assay was verified using our four padlock probes 
and STD synthetic targets. In the presence of HIV-1, NR, CT and TP synthetic targets, HRCA 
generates dsDNA amplification products that are hybridized with red and green fluorescent PNA 
probes. The resultant fluorophores-labeled HRCA products were scanned under Typhoon image 
scanner in both red (top row) and green (bottom row) channels. From left to right in each channel, 
the fluorescent spots represent fluorophores-labeled HRCA products of HIV-1, NR, CT, TP and 
H2O control samples respectively. The spots of fluorophores-labelled HIV-1 amplification products 
show weak fluorescence in red channel and strong fluorescence in green channel with measured 
R/G ratios of 0.86. While the spots of NG, CT and TP samples show strong fluorescence in red 
channel and weak fluorescence in green channel with measured R/G ratios of 1.93, 3.43 and 5.20 
respectively. The spot of H2O control sample shows no fluorescence signal in either red or green 
channel. (B) Our HRCA-based assay was also replicated in four separated experiments. Each 
measured target-specific R/G ratio is significantly different from each other and their small error 
bars indicate high reproducibility of our HRCA-based assay. Adapted with permission from [123]. 











Figure 3.5. Sensitivity of HRCA-based ratiometric fluorescence coding 
(A) The sensitivity of our HRCA-based ratiometric fluorescence coding method was verified using 
a gradient input of each STD synthetic targets ranging from 1 pmol, 1 fmol, 1 amol to 1 zmol. The 
fluorophore-labeled HRCA samples were scanned under Typhoon scanner in both red (left panel) 
and green (right panel) channels. The synthetic target inputs are HIV-1, NR, CT and TP from left 
to right in each row, and target input concentrations are 1 pmol, 1 fmol, 1 amol and 1 zmol from 
top to bottom in each column. The fluorescence intensities in both red and green channels were 
observed to decline as target input decreasing due to the deduction of dsDNA templates generated 
through HRCA. (B) For each target, the measured R/G ratios remained fairly consistent across the 
input concentrations, further indicating the robustness of our method. (C) Our HRCA-based assay 
was performed to detect 200 ng and 2ng of NR genomic DNA. The resultant fluorophores-labeled 
HRCA samples were scanned under in both red and green channels, and R/G fluorescence ratios 
were measured (left). R/G ratios of two NR genomic DNA samples were measured to be 
comparable to that of NR synthetic target using our HRCA-based assay (right). Adapted with 






Figure 3.6. Schematic illustration of Digital Ratiometric Fluorescence Coding method 
(A) We start with the mixture of our 6 target-specific padlock probes and DNA targets. After 
ligation, HRCA and hybridization of AF555- (red) and AF488- (green) labeled MBs, the droplets 
are measured on a custom confocal microscope system. (B) Droplets images. After MB 
hybridization, droplets were observed using a fluorescence microscope under white light (i), red 
channel (ii) and green channel (iii). Droplets with fluorescence indicated that at least one copy of 
circular padlock probe was capsulated into the droplet, while droplets without fluorescence 






Figure 3.7. Image of Microfluidic device for droplet generation and measurement 
The microfluidic device consists of a droplet generation module (green) and a droplet measurement 
module (red). Droplets are generated via a 10 µm flow-focusing junction (bottom left) and 










Figure 3.8. A schematic of the custom confocal microscope system 
The optical setup consists of dual laser excitation (488nm and 552nm) and dual band fluorescence 





Figure 3.9. Droplet fluorescence traces for different DNA samples 
Six synthetic oligonucleotides derived from conserved gene sequences of MG, HSV, NG, HIV, TP 
and CT were used as the targets in the Digital Ratiometric Fluorescence Coding assay. The 
fluorescence measurement on the confocal microscope system revealed that samples with different 
DNA targets indeed yielded R/G fluorescence ratios that were noticeably distinct from each other. 
For example, for the MG sample with pre-designed R/G ratio of 0:1, only green fluorescence was 
detected and no red fluorescence observed, while for the CT sample with pre-designed R/G ratio 





Figure 3.10. Comparison of single molecule counting and bulk fluorescence analysis 
Scatter plot for red and green fluorescence intensities of six samples with distinct R/G ratios. We  
used xix synthetic oligonucleotides derived from conserved gene sequences of MG, HSV, NG, HIV, 
TP and CT as the targets, challenged each of them to our mix of six padlock probes, and measured 
the red and the green fluorescence intensities of droplets from each sample. Red and green 
fluorescence of each droplet were measured on the confocal microscope system and the scatter plot 
for red and green fluorescence intensities in each sample revealed that the six target-specific R/G 






Figure 3.11. Average R/G fluorescence ratios and their standard deviations 
(A) Average R/G fluorescence ratios and their standard deviations were calculated from ratios 
measured on over thousands of droplets in each sample. The results have shown that six measured 
fluorescence ratios are noticeably distinct, indicating our Digital Ratiometric Fluorescence Coding 
assay for identifying STD-related gene sequences based on distinct R/G fluorescence ratios. (B) A 
linear regression is performed between average measured R/G ratios and pre-designed ones. The 
strong linearity between them with slope= 1.6643 and R2 = 0.9973 also provides strong support for 





Figure 3.12. Digital Ratiometric Fluorescence Coding method for multiplexed detection of 
STD-related gene sequences in a single reaction  
(A) Both NG and HIV synthetic targets were pre-mixed and tested using our Digital Ratiometric 
Fluorescence Coding. The resultant scatter plot for red and green fluorescence intensities present 
two populations that are unambiguously separated, indicating our assay for multiplexed detection 
of more than one target in a single reaction. Moreover, our Digital Ratiometric Fluorescence 
Coding has been demonstrated for multiplexed detection of four different STD-related gene 


















































Table 3.1. Padlock probe and synthetic target sequences for Ratiometric Fluorescence Coding 
assay demonstration 
Padlock probes targeting gene sequences in Proteus mirabilis (PM, 238:275 from AF240693) 
Human immunodeficiency virus 1 (HIV-1, 258:305 from KC966998), Neisseria gonorrhoeae (NG, 
362:411 from X52364), Chlamydia trachomatis (CT, 50:98 from JX648604), Treponema pallidum 
(TP, 801:846 from KC966998), and Escherichia coli (EC, 189:230 from AY447194) were designed 
for the demonstration of Ratiometric Fluorescence Coding concept. Adapted with permission from 









































Target_1_HIV 5’- CTTCCCCTTGGTTCTCTCATTTGGCCTGGTGCAATAGGCCCTGCATGC 








Table 3.2. Padlock probe and synthetic target sequences for Digital Ratiometric Fluorescence 
Coding Assay demonstration 
Padlock probes targeting gene sequences in Microplasma genitalium (MG, 1420:1473 from 
M31431), Herpes Simplex Virus (HSV, 1426:1473 from K01760), Neisseria gonorrhoeae (NG, 
362:411 from X52364), Human immunodeficiency virus (HIV, 258:305 from KC966998), 
Treponema pallidum (TP, 801:846 from KC966998) and Chlamydia trachomatis (CT, 50:99 from 





 Number of binding sites (S) 
Number of colors 4 5 6 … 10 
2 7 11 13 … 41 
3 22 40 55 … 226 





Table 3.3. Approximation of maximum number of fluorescence ratios based on our 
Ratiometric Fluorescence Coding strategy 
The maximum number of fluorescence ratios is calculated given the number of fluorescence colors 
and fluorescent probe binding sites using our Ratiometric Fluorescence Coding strategy. Adapted 





Chapter 4  
4. Single-molecule Fluorescence Spectroscopy for 
Telomere Length Measurement 
4.1 Background 
Telomeres are specialized DNA tandem repeats and protein structures that cap the 
chromosomal ends and protect the chromosomes from degradation by serving as sacrificial bases 
during each cell replication. The rate of attrition of these tandem repeats is around 50 to 200 base 
pairs with every cell division [124]. When telomeres become critically short, they trigger DNA 
checkpoint responses mediated by telomere-associated proteins that prevent further cell replication 
(Figure 4.1A(i)) [125-127].  
Dysfunction of telomeres can take the form of premature shortening (as in many hereditary 
telomere syndromes such as Dyskeratosis Congenita, Hoyeraal-Hreidarsson syndrome and 
pulmonary fibrosis) [125, 126] or lengthening. The latter frequently occurs in cancer, and is 
preceded by  failure to arrest replication in the presence of critically short telomeres [128, 129], 
and the rescue of ensuing cellular crisis by activation of either telomerase (85-90% of tumors) or 
proteins associated with alternative lengthening of telomeres (ALT, 10-15% of tumors) [127, 129, 
130]. This in turn permits the cells to multiply without constraint.  
Telomere length (TL) is also of great interest in the context of the ageing process. However, 
results from studies using TL to test a host of hypotheses related to the biology of human ageing 
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have often been inconsistent. In using average TL as the only parameter, these studies fail to take 
into account the heterogeneity of TLs on chromosome arms, first reported by Lansdorp, et al [131]. 
In fact, it is increasingly recognized that the deleterious effects of telomere dysfunction are 
mediated by the load of critically short telomeres [132-137]. For example, genetic studies in mice 
have shown that the shortest telomeres, rather than the average TL, are critical for chromosome 
stability and cell viability, and are likely a major cause of age-related pathologies [133]. This load 
can increase due to the gradual shortening of telomeres across all chromosomal arms during normal 
cellular aging. However, even without significant differences in average TL, the load of critically 
short telomeres between samples can differ significantly due to variations in the shape of the TL 
distribution, either between individuals or cell types (Figure 4.1A(ii)), or because of bi- or multi-
modal distribution that may occur as a result of catastrophic telomere loss [138-140], or species-
specific telomere biology (Figure 4.1A(iii)) [141].  Therefore, determining the distribution of 
absolute TLs is of great importance.  
Apart from monitoring natural TL changes, the prospect of telomere-lengthening treatment 
for various medical conditions and prolonging longevity has been raised in recent years. This can 
be achieved by transfecting cells with telomerase reverse transcriptase (TERT), resulting in 
significant telomere lengthening [142, 143]. In mouse studies, introducing TERT in adult and old 
mice resulted in improvements in all aging markers, increased longevity, without any increase 
cancer incidence [143]. A more recent study also raised the possibility of reducing telomere attrition, 
or even elongating telomeres in patients with various telomere diseases using androgen therapy 
[144]. While questions of safety (including the risks of cell immortalization) and efficacy (how and 
when to introduce the treatment) remain to be answered, these applications argue for the need for 
a method for determining TL profiles that has a higher throughput.  
The strengths and weaknesses of existing TL measurement methods, which have been well 
documented in literature, are briefly summarized below [136, 145]. Despite their high sensitivity, 
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quantitative polymerase chain reaction (qPCR) methods using primers specific to the telomere 
repeat sequence yield only average TL for a given sample [57, 58]. Flow-fluorescence in situ 
hybridization (Flow-FISH) fluorescently labels telomeres in blood cells that are then analyzed by 
flow cytometry and gives the distribution of total TL in each cell [145-147]. Neither method can 
detect small fractions of critically short telomeres among all chromosomal ends, arguably the most 
important telomere biomarker. Although terminal restriction fragments (TRF)/Southern blot 
analysis can in principle yield information of the size distribution of telomeres, it is only semi-
quantitative, with relatively poor sensitivity, particularly for shorter telomeres [148, 149]. 
Furthermore, the size estimates are skewed by the presence of a sub-telomeric sequence of variable 
size on each fragment, limiting their utility, which we discuss about in the following chapters [149].  
A newer PCR-based approach known as single telomere length analysis (STELA) using 
chromosome-specific primers provides the TL of specific chromosomal arms [145, 150]. However, 
STELA fails to adequately capture the complete picture of the TL dynamics within cells since 
primers exist for less than one-fifth of all chromosomal arms [145]. Lastly, quantitative FISH (q-
FISH) is able to provide an abundance of information, including chromosomal arm-specific TL. 
However, the method requires cells that can be induced into metaphase, and thus precludes its 
application to archival samples such as frozen DNA samples. Furthermore, sample preparation is 
very time consuming and labor intensive, thus severely limiting its practical applications [145]. 
Against this technical backdrop we have developed a method dubbed peptide nucleic acid 
(PNA) Hybridization and Analysis of Single Telomere (PHAST) assay to determine the length of 
telomeres, hybridized with fluorescent probes, via analysis of single telomere fluorescence 
measured by a light-sheet fluorescence spectroscopic method [68, 69]. Starting with genomic DNA, 
the entire sample preparation procedure takes less than 3 hours, including a 2-hour PNA 
hybridization interval. Telomere molecules are detected one at a time as they transit an observation 
volume (OV), generating single-molecule fluorescence bursts. The properties of these bursts are 
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then analyzed and used to gate the telomere populations, in an approach akin to flow cytometry, to 
remove spurious bursts and improve the detection limit. By leveraging the unique capabilities of 
single molecule detection, we have been able to determine the telomere size distribution with DNA 
from small numbers of cells 
4.2 Experimental Details 
4.2.1 CICS Instrumentation 
The instrumentation for CICS is identical to that previously reported [68, 69]. Briefly, an 
Ar-ion laser (488 nm, Melles Griot, Carlsbad CA) is passed through an optical fiber and additional 
shaping optics that expand the laser spots into large illumination discs, which are then focused into 
a light sheet using a cylindrical lens. The power output as the beam exits the coupler is adjusted to 
2.5 mW prior to each experiment. The light is then focused into a microfluidic channel using a 
100 oil immersion microscope objective (UPlanFl, Olympus, Center Valley PA). The objective 
collects the emitted photons from the sample in an epifluorescence configuration, and a dichroic 
mirror (z488/633rpc, Chroma Technology, Bellows Falls, VT) is used to separate the excitation 
light and emission fluorescence. A confocal aperture (600  150 µm, National Aperture, Salem, 
NH) is used to spatially filter out out-of-plane light, yielding an effective detection volume of 7  
2 µm on the microfluidic chip.  Finally, dichroic mirrors and band-pass filters (Omega Optical, 
Brattleboro, VT) are used to spectrally separate the green and red fluorescence and to select the 
desired wavelengths for detection on the avalanche photodiode (APD SPCM-AQR13, Perkin Elmer, 
Vaudreuil, Quebec, Canada).  Fluorescence data is collected and processed using custom software 
using the Labview interface. 
4.2.2 Telomeric Standards Generation 
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Telomere length standards were synthesized through a repeated extension process. Initial 
telomere template (90 bp) was synthesized by Integrated DNA Technologies, Inc. (Coralville, IW), 
with KpnI and XhoI site at 5’ end and SalI at 3’ end containing 12 telomere repeats 
(GGTACCTCGAGGG-(TTAGGG)12-TCGAC). Two additional forward (5’-
TGGTACCTCGAGGGTTAGG-3’) and reverse (5’-GTCGACCCTAACCCTAACC-3’) primers 
that can anneal to the telomere template at both ends were synthesized and used in a PCR reaction 
to create a double strand telomere template which was then ligated into pCR4-TOPO TA vector 
(Life Technologies, Grand Island, NY), and sequence verified by Sanger DNA sequencing (Genwiz, 
Germantown, MD). The telomere template insert was then released from the TA vector by XhoI 
and SalI digestion. After separation by electrophoresis on a 1.5% agarose gel and band purified 
with a DNA gel purification kit from Qiagen, the double-strand template was further cloned into 
the XhoI site of pUC19 (New England Biolabs, Ipswich, MA (NEB)). To use as a subsequent 
hosting vector, this obtained plasmid was cut with XhoI. To prepare telomere insert for extension, 
the cloned insert in the plasmid was released with KpnI and SalI, or by amplification with PCR 
using the plasmid as template and two primers annealing to pUC19 beside the cloned insert 
(pUC19-F: 5’-AGTGAATTCGAGCTCGGTAC-3’ and pUC19-R: 5’-
CAAGCTTGCATGCCTGCAG-3’) followed by digestion with SalI. Finally, the prepared hosting 
vector and telomere extension insert were mixed and fused together with a Gibson Assembly 
cloning kit (NEB) to have the telomere insert in the hosting vector extended. This process was 
repeated several times in order to obtain longer telomere inserts. To check the length, telomere 
inserts were released with XhoI and SalI digestion and run on a 1.5% agarose gel. 
4.2.3 DNA Digestion by Restriction Enzyme 
To digest the DNA samples, we incubate 20 µL of the DNA (typically between 1-5 µg total 
DNA) with 4.39 µL of a mixture of RsaI and HinfI restriction enzymes (Roche Applied Sciences, 
1000 units) and Buffer A (Roche) (1:1:2 volume ratio) at 37 °C for 2 hours. 
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4.2.4 Single-tube Purification and Hybridization 
To minimize the DNA fragmentation during telomere preparation, we chose to apply 
phenol/chloroform extraction, which is considered as the gold standard to produce high-purity and 
high-molecular weight DNA with minimal shearing. Genomic DNA is extracted from cell lines 
using phenol/chloroform extraction and added to a 150 µL proprietary PNA hybridization buffer 
containing 500 pM of telomere-specific biotinylated PNA probes (pcTel-Bio, PNA Bio Inc.). After 
a 10 minutes incubation at 85 °C, the mixture is left at room temperature for 30 minutes. 20 µL of 
streptavidin-coated magnetic Dynabeads C1 (Life Technologies) is then washed in 1X Binding 
Washing (BW) buffer as described by manufacturer, resuspended in 150 µL 2X BW buffer and 
incubated with the DNA/PNA mixture for 30 minutes on a rotating sample holder. The pulled-
down DNA is then washed with 1X BW buffer to isolate the telomere-containing DNA. 
4.2.5 Fluorescent PNA Hybridization 
DNA samples in solution are mixed directly with 500 nM Alexa 488 labeled PNA (PNA-
AF488, PNA Bio Inc.) in PNA hybridization buffer, incubated at 85 °C for 10 minutes and left at 
room temperature in the dark for 2 hours to complete the labeling. For DNA samples bound to 
magnetic beads, the telomeric DNA is released from the pcTel-Bio/Dynabeads upon heating and 
placed on a magnetic holder prior to incubation at room temperature to isolate the telomeres from 
the beads. The large excess of PNA-AF488 ensures minimal re-hybridization onto the beads. 
Finally, the samples are purified with S400-HR microspin columns (GE Healthcare) to remove the 
excess PNA-AF488. 
4.2.6 Telomere Sizing on CICS 
Microfluidic devices are fabricated as described previously [68, 69, 151]. The purified 
samples are flowed through a 5 µm x 0.5 µm microfluidic channel (w x h) using a pressure 
controller (Alicat Scientific) and detected on CICS. Emitted photons are counted at 0.1 ms intervals. 
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To ensure representative data, the pressure is adjusted to ensure that the average transit time of the 
samples through the CICS detection volume is at least 3 ms. Gating to exclude spurious peaks is 
performed as described in Chapter 4.6. A standard curve is constructed using linearized cloned 
telomere standards (0.1, 0.2, 0.4, 0.9, 1.2 and 2.4 kb TL), relating the height of the fluorescence 
peak to the length of the DNA. We have found that the fluorescence peak height varied linearly 
with TL and is invariant between experiments. Therefore the same standard curve is used for size 
estimation. For TLs exceeding the range of the standards, a linear extrapolation is used to estimate 
their sizes as discussed in the Chapter 4.8. In addition, 3 µg of HeLa genomic DNA (NEB) was 
processed using our PHAST assay as described above and the resultant telomere length was 
compared with that measured by TRF (Chapter 4.9). 
4.2.7. Determination of Pull-down Efficiency 
To determine the efficiency of the pull-down assay, a mixture of telomeric standards (0.2, 
0.4, 1.2 and 2.4 kb) at high (1.60, 1.64, 1.84, 2.16 ng respectively) and low concentrations (40, 41, 
46, 54 pg respectively) was mixed with 1µg of heat-fragmented genomic DNA (~ 100-1000 bp) 
prior to sizing with PHAST assay (200 µL final volume). As controls, telomeric standards was 
mixed at the same proportions and hybridized with PNA-AF488, without going through the pull-
down process. The pull-down efficiency of each species is then determined by comparing the 
number of molecules detected with and without pull-down. 
4.2.8 Comparison of PHAST with q-FISH 
WI38, U2OS and R83 cells were purchased from ATCC (Manassas, VA) and cultured in 
the medium as recommended by the vendor. Human primary fibroblasts were the gift of Drs. 
Xuefeng Liu and Richard Schlegel in the Molecular Oncology Programs, Lombardi 
Comprehensive Cancer Center, Georgetown University. The cells were cultured in DMEM plus 
10% FBS, and harvested at metaphase, followed by chromosome preparation according to the 
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method described previously [152]. The same batch of cells in separate flasks were harvested with 
0.1% Trypsin/EDTA (Invitrogen, Rockville, MD), and genomic DNA from cell pellet were purified 
with DNA purification kit (Qiagen, Germantown, MD). The quality and concentration of the DNA 
was measured with Nanodrop. 
Chromosome arm-specific telomere length was measured by telomere quantitative 
fluorescence in situ hybridization (q-FISH) as previously described [153]. Briefly, chromosome 
preparations were dropped onto clean microscopic slides and hybridized with 15 µL of 
hybridization mixture consisting of 0.3 µg/ml Cy3-labeled telomere-specific PNA probe (PNA Bio 
Inc.), 1 µL of cocktails of FITC-labeled centromeric PNA probes specific for chromosomes 2, 4, 8, 
9, 13, 15, 18, 20 and 21, and 20 µg/mL of Cy3-labeled centromeric PNA probes specific for 
chromosome X (Biomarkers, Rockville, MD), in 50% formamide, 10 mM Tris-HCl, pH 7.5, and 
5% blocking reagent.  Slides were denatured and then hybridized at 30°C for 3 hours. After 
hybridization, the slides were sequentially washed 10 minutes each at 42°C: once in 1 x SSC, once 
in 0.5 x SSC, and once in 0.1 x SSC. The slides were then mounted in anti-fade mounting medium 
containing 300 ng/ml DAPI. 
After q-FISH, cells were analyzed using an epifluorescence microscope equipped with a 
charge-coupled device (CCD) camera. Metaphase cells were captured with exposure times of 0.15, 
0.25 and 0.05 second for Cy3, FITC and DAPI signals, respectively. Digitized metaphase images 
were analyzed using the Isis software (MetaSystems Inc. Boston, MA), which permits the 
measurement of 92 telomere signals simultaneously after karyotyping. Telomere fluorescence 
intensity units (TFU) were recorded as an indirect measurement of telomere length. For each 
sample, at least 12 metaphase cells were analyzed.  Each pair of homologous telomeres was 
recorded separately as homologous short (S) and homologous long (L).  
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PHAST assay was performed on three cell lines, namely WI-38, R83 and U2OS. A total 
of around 5 µg genomic DNA is processed as previously described. q-FISH results were obtained 
from our collaborators at Georgetown University. Since q-FISH does not provide absolute telomere 
length, the TFU are scaled to match the mode of the TFU histogram to the telomere length 
histogram calculated using PHAST. 
Similarly, PHAST assay was performed on three clinical samples (two from cancer patients, 
one from a control subject). Genomic DNA was isolated from three clinical blood samples 
(BA01628, BA01650, CB3319) obtained from our collaborators at Georgetown University. For 
each clinical sample, a total of around 500 ng genomic DNA was processed as described previously. 
Q-FISH results were also obtained from our collaborators who offered the clinical samples for 
comparison. 
4.2.9 Telomeric Sequence Generation via Rolling Circle Amplification 
It is difficult to obtain telomere standards longer than 2.4 kb because the cloning vector is 
unable to accept a much larger cassette. As a result, we employed padlock probe chemistry [106] 
and Rolling Circle Amplification [107] to produce longer telomeric sequences. We design our 
padlock probe to contain two non-telomeric regions at 5′ and 3′ ends, and an internal part consisting 
of 9 repeats of CCCTAA sequences. In the presence of oligo sequence complementary to the non-
telomeric regions, padlock probe is ligated to a closed circle for subsequent amplification and result 
in single strand DNA over 20kb, a substantial proportion of which are telomeric sequences. The 
sequence of our padlock probe is 5'/Phos/-GGAACCCGATATAATCCGCCCTTCCCTAAC 
CCTAACCCTAACCCTAACCCTAACCCTAACCCTAACCCTAACCCTAAATATTGTGTTG
AAACACCGCCC. The sequence of RCA primer is 5'-GGGTTAGGGTTAGGGTTA and the 
sequence of complementary non-telomeric oligo is 5'-AAGGGCGGATTATATCGGGTTCCGG 
GCGGTGTTTCAACACAATATGGCGG. All DNA oligonucleotides were purchased from 
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Integrated DNA Technologies, Inc. (Coralville, IA). Reagents for ligation and RCA reactions, 
including 9°N™ DNA Ligase, 10× 9°N™ DNA Ligase Reaction Buffer, Phage ø29 DNA 
Polymerase, Exonuclease I (E. coli), Exonuclease III (E. coli) and 10× Isothermal Reaction Buffer 
were purchased from New England BioLabs, Inc. (Ipswich, MA). 
Padlock probe hybridization and ligation was achieved in a 25-µL reaction mixture 
contained 150 nM of padlock probe, 400 nM of complementary non-telomeric oligo, 0.4 Units/µL 
9°N™ DNA Ligase, and 1× 9N DNA Ligase Reaction Buffer (10 mM Tris-HCl, 600 µM ATP, 2.5 
mM MgCl2, 2.5 mM Dithiothreitol, 0.1% Triton X-100, pH 7.5 at 25°C). Padlock probe 
hybridization and ligation was performed at 60 °C for 1 hour. Then 25 μL of the ligation product 
was treated with 10 units of Exonuclease I and 50 units of Exonuclease III at 37 °C for 1 hour to 
remove extra padlock probes that were not circularized. After digestion, 5 μL of the enzyme-treated 
ligation product was mixed with 200 nM RCA primer, 400 μM dNTPs, 10 U/µL Phage ø29 DNA 
polymerase, and 1× Isothermal Reaction Buffer (50 mM Tris•HCl (pH 7.5), 10 mM MgCl2, 200 
μg/mL acetylated BSA) to a final volume of 25 µL. Of note, due to its high strand-displacing 
activity, Phage ø29 DNA polymerase was added last to the reaction mixture, which was then 
immediately incubated at 31 °C for 1 hour to perform RCA, followed by 70 °C for 10 minutes to 
inactivate the polymerase and stop the reaction. 
4.2.10 Application to Huntington CAG Tandem Repeats 
To apply our method for Huntington CAG tandem repeat, a 12nt Alexa 488 labeled PNA 
(5’-Alexa488-CTGCTGCTGCTG, PNA Bio Inc.) was used to label the CAG trinucleotide repeat 
oligonucleotide. The CAG repeat oligonucleotide contains 66 CAG trinucleotide repeats ((CAG)66, 
Integrated DNA Technologies, Inc.), which allows the hybridization of a maximum of 16 PNA 
probes. The protocol for fluorescent PNA hybridization is similar to that in our PHAST method 
described above. 500 pM CAG repeat oligonucleotides were mixed directly with 500 nM PNA in 
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PNA hybridization buffer, incubated at 85 °C for 5 minutes and left at room temperature in the dark 
for 2 hours to complete the labeling. Then the purified sample was flowed through the microfluidic 
channel and detected on CICS. 
4.3 Overview of PHAST 
The PHAST protocol begins with total genomic DNA extracted from cells using standard 
phenol/chloroform extraction, taking care to avoid shearing the DNA molecules (Figure 4.1B). 
Telomeric DNA is pulled down using biotinylated PNA probes that hybridize to the telomere 
sequence, and streptavidin-coated magnetic beads. After the non-telomeric DNA has been 
discarded, the sample is heated to release the telomeres from the beads in the presence of excess 
Alexa488-labeled PNA (PNA-AF488). The magnetic beads are then discarded and the labeled 
telomeres are ready to be analyzed. 
The sample is introduced into a microfluidic device on a custom-built microfluidic single 
molecule detection (SMD) instrument as described previously (Figure 4.1C) [68, 69, 151]. Briefly, 
the microchannel spatially confines each passing PNA-AF488 labeled telomere into the path of a 
laser beam, in a manner analogous to the sheath/core flow configuration in flow cytometry. Typical 
SMD instruments utilize a diffraction-limited laser spot with a Gaussian profile to excite the 
fluorescently labeled targets [154]. As a result, the brightness of each single molecule fluorescence 
burst depends on both the number of dyes on the molecule, as well as the excitation intensity 
through which it traverses. The inability to decouple these two contributing factors yields highly 
variable fluorescence signal from even a uniform sample, and limits SMD’s ability to characterize 
individual molecules. To address these limitations, PHAST uses a cylindrical illumination confocal 
spectroscopy (CICS) configuration, wherein the excitation illumination is modified using beam-
shaping optics to give an OV in the shape of a uniform light sheet that extends across the entire 
microchannel cross-section (Figure 4.1C) [68, 69, 151]. Not only does this allow quantification of 
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the number of PNA-AF488 probes on the telomeres, but it also ensures that every single telomere 
molecule passing through the microchannel is accounted for, thereby eliminating sampling bias, 
and in principle permitting the use of very few cells for quantification. 
4.4 Single-molecule Fluorescence Peak Parameters Modeling 
Detection of the fluorescently labeled telomere is performed in a microfluidic channel as 
described previously [68]. Briefly, a solution containing the labeled telomeres is driven through the 
microchannel using a pressure source at various settings. An expanded laser (488 nm Argon ion 
laser) confocal spot spans the entire cross-section of the microchannel, and as each molecule passes 
through this region, it is excited and the emitted photons are collected by an avalanche photodiode 
(APD). The fluorescence signals collected from the molecules at 0.1 ms intervals are processed 
using custom Labview software. ND filters are applied when more than 10% of the peak heights 
exceed 1,000 photon counts per 0.1 ms interval in order to prevent detector saturation. We define 
a peak (or burst) as having been detected when the fluorescence intensity exceeds a pre-determined 
threshold, t (= 100 and 40 photon counts when no ND and ND 0.5 is applied to the laser source, 
respectively) (Figure 4.2A). To minimize measurement artifacts arising from fluorescence 
fluctuation around the threshold, the beginning and end of each peak are signified when the 
fluorescence drops below the baseline value, b (= 40 and 15 for no ND and ND 0.5). The having 
different values for t and b ensure that signal fluctuating around the threshold will not register as 
multiple peaks.   
For each fluorescence peak, the time interval between the points at which the signal crosses 
a lower baseline level along the rising and falling edges is defined as the Width of the burst. The 
maximum intensity and total fluorescence (less the baseline) of each burst are the Height and Size, 
respectively. This thresholding procedure ensures that a fluorescent molecule, which barely 






respectively. It is worth noting here that while the horizontal axis in Figure 4.3 is in terms of 
position (i.e. y-value), it can be converted into a time axis if the velocity is known since the APD 
samples the fluorescence at fixed time intervals.  
The DNA diameter corresponding to the largest telomeres (~ 0.3 microns for 10 kb 
molecules) is comparable to the size of the Gaussian OV, which has a 1/e2 diameter of around 0.25 
micron along the flow axis [68]. Consequently, the peak profile for long telomeres is intermediate 
between Gaussian and parabolic, for which no simple analytical solution exists. Nevertheless, 
numerical approximations of the peak profile for different DNA lengths and the corresponding 
parameters can be calculated using mathematical software (Wolfram Mathematica 9).  
S-values are obtained by integrating the peak shape over the time interval, W, which is 
determined using the same threshold that is used for the experimental data. To obtain the peak 
height or H from this model, it is noted that the maximum signal occurs when the Φ and OV 
functions are centered, i.e. when the DNA lies at the center of the OV, such that I (0, L). To 
recapitulate the peak shape using the model, only two variables have to be chosen empirically using 
our experimental data. The first is the k-value, which is a single factor to account for excitation 
intensity, detector efficiency, DNA labeling density, and dye quantum yield. The second is a scaling 
factor applied to both S and W to account for velocity. 
Comparing the peak heights and widths from the model with experimental results obtained 
from Hind III digested λ DNA labeled with TOTO-3 indicates a good fit between the two (Figure 
4.4). The λ DNA digest system was chosen because the sizes of the fragments are well defined, and 
the longest fragment is larger than 20 kb, as opposed to only 2.4 kb for our telomere standards. This 
allows us to examine the accuracy of the model when deviating from the point emitter idealization. 
Furthermore, since any difference between the Hind III digest and Alexa488-labeled telomere 
systems can be accounted for by adjusting the k (incident intensity, dye quantum yield, and labeling 
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density) and c (width of the Gaussian OV) factors, there are no explicit reasons to expect significant 
differences between this and the telomere system. Thus, the model should be able to account for 
both these systems with minimal change. Derived essentially from first principles, the extensive 
agreement between the model and experimental data suggests that the model does indeed describe 
the physical system, and can be used to inform our gating strategy (details in Chapter 4.6), and 
even predict the peak parameters. 
4.5 PHAST One-Tube Purification Assay 
For a typical sample, total genomic DNA contains a large amount of non-telomeric 
sequences. In fact, telomeres constitute around just 0.01-0.02% of the total DNA mass. As a result, 
even though only a small proportion of genomic DNA will hybridize non-specifically to the Alexa 
488 labeled PNA (PNA-AF488) probes, the sheer abundance and different sizes of these molecules 
makes them difficult to remove by size selective methods (dialysis, microspin columns, etc). 
Because each DNA molecule is expected to bind very few PNA probes in this manner, the presence 
of these non-specifically labeled molecules manifests as a generally higher background, which 
increases the chance of erroneous detection. Furthermore, since we define the start and end of peaks 
as the points at which the photon count crosses the baseline level (Figure 4.2B), if the background 
were to approach or exceed the baseline, it will cause errors in the measurement of all peak 
parameters, since the demarcation between one peak and the subsequent one(s) may not be possible 
to ascertain. 
To address this, we developed a one-tube purification assay to allow removal of virtually 
all of the non-telomeric DNA molecules (Figure 4.5). Briefly, telomere-containing DNA 
molecules are hybridized with biotinylated telomere-specific PNA capture probes (pcTel-Bio) 
without any prior digestion, then immobilized on streptavidin-coated magnetic beads, allowing the 
non-telomeric DNA fragments-containing supernatant to be removed (Figure 4.5, Steps (I)-(III), 
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Panels A and B). After rinsing, the captured telomeres are released into a solution of PNA-AF488 
probes at an elevated temperature. By using 100 times as much PNA-AF488 probes as biotinylated 
ones, we ensure that the fluorescent probes will compete favorably against any biotinylated capture 
probes that remains in solution (Figure 4.5, Steps (IV)-(V), Panels C and D). This whole process 
is performed in a single tube, and thus further development such as automation and implementation 
on a microfluidic platform is uncomplicated.  
To demonstrate the effectiveness of the pull-down protocol, 45 pg of 2.4 kb telomere 
standard in 1 µg of genomic DNA is processed. The gel image (Figure 4.6A) shows the intense 
fluorescence due to the genomic DNA, which completely obscures the telomere band. After the 
pull-down procedure, the telomeric band can be clearly seen (white dashed box). Non-specific pull-
down of long genomic DNA fragments invariably occurs. However, due to the specificity of the 
biotinylated PNA probes, these fragments are not in sufficient concentrations to show up in the 
CICS trace (Figure 4.6B, C). The pull-down step greatly reduces the background fluorescence, and 
thus improves the performance of PHAST. 
To ensure that the pull-down purification process does not bias the TL distribution, 
telomere standards at known ratios (total telomere mass of 180 pg) are spiked into heat-fragmented 
genomic DNA (~100-1000 bp, 1 µg), and purified using our procedure. At this relative telomere 
concentration, which is comparable to that expected from mammalian genomic DNA, telomeres 
were recovered in a size-independent manner (~ 50% for all tested TLs, Figure 4.6D, blue bars). 
However, when much higher concentrations of telomere standards were used (16 ng in 1 
µg), we found that the relative pull-down efficiency of the DNA increases with the length of the 
telomere (Figure 4.6D, red bars). This observation can be explained by noting that, in general, we 
expect the number of biotinylated probes bound to the telomeres to be proportional to the TL. 
Furthermore, assuming that streptavidin/biotin binding is non-cooperative (a reasonable 
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assumption since it is unlikely for adjacent biotinylated PNAs to bind to the same streptavidin 
molecule), and since a single successful tether is sufficient to capture a DNA, the association rate 
of the telomeres will scale with the number of bound biotinylated PNA [158]. Because 
streptavidin/biotin conjugation can be considered to be an essentially irreversible process, the 
relative pull-down efficiency for telomeres of different lengths will depend only on the association 
rate, though partially mitigated by the differences in diffusivity and steric hindrance. If the number 
of streptavidin is insufficient to pull down all the telomeres, the faster binding rate of longer 
telomeres with more biotin hybridized to them ensure that they will occupy a larger portion of the 
available surface. 
4.6 Gating Procedure for Background Removal 
detect the shortest telomeres, the threshold is lowered to improve the detection limit. This 
increases the thresholding artifacts, which occur when the background noise drifts above the 
threshold, tend to hover around the baseline, such that 
Sizeartifact ~ (Widthartifact /interval)  baseline                                         (14) 
 As a result, the log10(width)/log10(size) slope for the artifacts is approximately 1. On the 
other hand, based on the model described previously, it is determined that the peak width increases 
fairly slowly with DNA length and hence peak size (log10(width)/log10(size) slope ~ 0.2 for the 
conditions tested).  
These characteristics have been exploited to formulate the gating strategy for the peaks. By 
clustering the peaks, two subpopulations can be clearly identified (Figure 4.2C). As can be seen in 
Figure 4.7, a simple threshold in any of the parameters (burst Size, Width or Height) will fail to 
adequately separate the actual and spurious peaks. On the other hand, a two-dimensional 
(width/size) gate can separate them (Figure 4.7A, red dashed box). Selecting the cluster with the 
smaller slope allows us to include many more peaks than merely using a higher threshold, while 
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also excluding the spurious ones. All the cell and tissue samples were gated in this manner and 
compared to the q-FISH results. 
4.7 Single-molecule Fluorescence Burst Analysis of Telomeres 
In PHAST, events of single-molecule fluorescence bursts of telomeres are identified from 
the raw fluorescence signals using a predetermined threshold (Figure 4.2A).  The parameters (i.e. 
Size, Width and Height) are employed, together with a theoretical framework based on the model 
of peak parameters described above to formulate a strategy for isolating true signal bursts from 
background fluctuation. Depending on the background noise level, some spurious bursts will 
invariably be acquired due to signal fluctuation (Figure 4.2B). Such peaks can be efficiently 
removed by selecting a sufficiently high threshold at the expense of assay sensitivity. However, 
since the abundance of the shortest telomeres are of greatest interest, our chosen threshold, which 
corresponds to TLs of as little as 65 bp, is low enough to pick up a significant number of spurious 
peaks, particularly in the presence of relatively large quantities of residual non-telomeric DNA (as 
discussed in chapter 4.5). These real and spurious peaks form two distinct clusters in a Width/Size 
plot (Figure 4.2C). This is because the background drifts that cause the spurious peaks typically 
hover around the baseline, with a nominal burst Size that is proportional to Width, i.e. the spurious 
cluster will have a slope of ~ 1 on a log-log plot of the two parameters. On the other hand, the 
physical constraints of the OV size, DNA length, and flow velocity place limits on the possible 
Width values of peaks associated with the detection of actual fluorescent molecules, and as such 
the corresponding cluster will have a gentler slope on the same plot. This is corroborated by the 
theoretical estimates (slope ~ 0.2, as described in chapter 4.4). Based on these distinguishing 
features, a gate is constructed that can isolate the spurious cluster (Figure 4.2C, D, chapter 4.6).  
One limitation of previous implementations of CICS is that, since the total number of 
photons in a burst is proportional to the residence time in the laser excitation volume, comparison 
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between different samples can only be made if the flow velocity is accounted for. Furthermore, 
because the pressure-velocity relationship depends on a number of factors, including microchannel 
geometry variation, surface properties, etc. the actual velocity in each experiment cannot be 
determined easily. By analyzing the parameters of telomere standards of different lengths (0.2, 0.9 
and 2.4 kb) run through the PHAST instrument at different pressures, the effects of velocity on 
PHAST parameters are apparent (Figure 4.2E, F).  Positions of the clusters in the Width/Size plot 
can be decoupled into two components, along the Flow Velocity Axis and Telomere Length axis. 
Since both Width and Size scale linearly with flow velocity, the Flow Velocity Axis has a slope of 
~1. This allows the same gate defined previously for removing spurious peaks to be used regardless 
of flow velocity. In fact, we found that the flow velocity had minimal effect on the burst Height, 
with only a 10% change when the flow velocity is increased 8-fold (Figure 4.2F). This translates 
to a smaller coefficient of variation (CV) for Height (10%) compared with Size (25%) in the length 
estimation of a 2.4 kb standard. Therefore Height is chosen as the parameter for telomere length 
estimation. Given the parallels between this CICS-based fluorescence spectroscopic approach and 
flow cytometry, we have named it fluorescence flow moriometry (Gr. mório, molecule or small 
particle, + metron, to measure), of which PHAST is one of many applications. 
4.8 Measurement of Telomere Standards by PHAST 
Previous implementations of CICS utilized peak burst size for quantification. Since peak 
size changes with flow velocity (slower moving molecules will reside in the OV longer, resulting 
in larger number of total detected photons), a calibration step is necessary to account for different 
flow speeds. Although the flow velocity varies linearly with the driving pressure, the exact linear 
relationship (the slope, x- and y-intercepts) changes from chip-to-chip, depending primarily on the 
hydrophobicity of the PDMS microchannel (which increases with time after oxygen plasma 
bonding with glass), and to a lesser extent the variations in the dimensions of the microchannels. 
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Since we can only control the driving pressure directly, there is no way to be certain of the flow 
velocity without utilizing flow tracers such as fluorescent microspheres [68, 69, 151]. 
Flow tracers typically require a separate fluorescence channel (that is, an additional laser 
excitation source and emission detector) that is coincident with the sample channel. This is non-
trivial since the alignment of the optical components has to be extremely close. Since light of 
different wavelengths focus at slightly different positions along the optical axis, it is necessary to 
record the two spectral channels sequentially, with an additional focus adjustment step in between. 
Doing away with the flow tracers greatly simplifies the demands on the instrumentation. For the 
existing CICS instrument, a tracer-free CICS also frees up an additional spectral channel to permit 
simultaneous multi-color detection.  
In our model, changes in flow velocity merely broaden peaks proportionately, resulting in 
a simple scaling of the peak sizes and widths without any change to the shape of peaks. This was 
borne out by experimental data where the slope of log10(width)/log10(size) curve for each telomere 
standard hybridized with Alexa 488-labeled PNA at different driving pressures has a slope of 
around 1 (Figure 4.2E). Furthermore, since the log10(size)/log10(width) curve for each velocity has 
the same slope (~0.2) and thus never intersects with another, a characteristic curve corresponding 
to each flow velocity can be obtained. Consequently, each log10(size)-log10(width) co-ordinate 
corresponds to a unique velocity and telomere length (TL), i.e. for a given set of experimental 
conditions, we expect all the real peaks to lie parallel to the TL axis (Figure 4.2E). 
Peak size (i.e. total photons detected during the transit of a fluorescent molecule through 
the detection volume) is, in principle, the best measure of the actual TL, once the flow velocity is 
accounted for. This is because each fluorophore has the same path integral in CICS, and hence the 
total number of detected photons corresponds to the total fluorophore content, and by extension TL, 
regardless of the spatial distribution of the fluorophores (i.e. peak shape). However, fluctuations in 
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the flow velocity are inevitable, which introduce additional variation to the peak size. This variation 
can be observed in Figure 4.2E, where each cluster of peaks is elliptical, with its long axis 
approximately parallel to the Flow Velocity axis. A transformation can be performed to convert the 
flow velocity and TL axes into an orthogonal pair for simple telomere sizing. Alternatively, given 
the consistent ellipsoidal molecular shape for all the expected DNA molecules (as discussed in the 
previous chapters), peak height can also be utilized for telomere sizing.  
The model predicts that in general, the peak height is a good proxy for each TL that is 
independent of flow velocity, except when the velocity is high enough to render the sampling rate 
inadequate, or if the DNA molecule is much larger than the OV. The former can be seen in minimal 
shifts in peak heights (~10%) with an 8-fold change in flow velocity when the driving pressure was 
increased from 0.25 to 2 psi (Figure 4.2F). Therefore, by simply flowing the samples through the 
microchannels at adequately low pressures (~ 0.5 psi), it is possible to obtain good TL estimates 
without correcting for the exact velocity. 
Because most of the DNA molecules are small compared with the Gaussian OV and hence 
well described by the scaling parameter κ (Chapter 4.4), peak height also varies linearly with TL 
for relatively short telomeres (< 10 kb). On the other hand, very long DNA molecules deviate from 
the point-emitter idealization. In these cases, the fluorophores are much more spatially distributed, 
and only part of the DNA lies in the detection volume at any point in time, and thus results in a 
decrease in the maximum instantaneous fluorescence (i.e. the peak height). While the telomere 
standards are too short for us to observe this drop-off (the longest telomeric segment is only 2.4 kb 
long), both the initial linear relationship and the subsequent drop-off were observed experimentally 
for Hind III digested lambda DNA (Figure 4.4). Although this nonlinearity presents some 
uncertainty in obtaining TL values from peak height by extrapolation, for TLs up to 10 kb in length, 
a linear approximation is deemed sufficient. Even for telomeres up to 30 kb in length, the linear 
approximation underestimates TL by only 15-20%. Therefore, the peak height is considered 
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adequate as a general sizing approach. Based on our experiments, the conversion from peak height, 
H, to TL can then be performed by a simple linear transformation, where 
TL (kb) = (H– 50)/780                                                        (15) 
for Alexa488 labeled probes. 
Based on the values derived from telomere standards of known lengths (0.1 to 2.4 kb), 
burst Height is related to telomere length through a simple linear relationship (Figure 4.8A). The 
TL estimates has a CV of around 10-25%, with greater uncertainty for shorter telomeres (Figure 
4.8A, B), as well as very good reproducibility for three independent sets of standards tested at 6-
month intervals (CV < 11%, Figure 4.8A, Table 4.1). Although we expect the linear relationship 
to break down for much longer telomeres, it remains a valid approximation for up to 10-15 kb 
telomeres (the average TL of neonates) [131, 147], and underestimates the actual TL by only 15-
20% for 30 kb telomeres, which is far longer than telomeres normally found in humans. To ensure 
that the gating procedure does not skew the TL estimates, a 2.4 kb telomere sample was tested with 
and without genomic DNA background. The resulting TL distribution was found to be unaffected 
by the gating procedure (Figure 4.8C). 
Considering the fact that the size of our telomere standards is limited to 2.4 kb because the 
cloning vector is unable to accept a larger cassette, we used padlock probe chemistry in conjunction 
with rolling circle amplification to generate long DNA molecules containing telomeric sequences 
to simulate long telomeres (Figure 4.9A). Like real telomeres, each sample prepared will contain 
DNA molecules of different lengths. By subjecting the sample to the pull-down process and 
comparing the telomere distribution determined by PHAST before and after the pull-down, we 
determined that our process did not bias the telomere size distribution, as evidenced by the linearity 
of the Q-Q plot (Figure 4.9B). Furthermore, it is worth noting that some of the telomeres detected 
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here were longer than 10 kb. This is comparable to the telomere lengths found in cells, and the 
absence of bias confirms the veracity of our length estimates. 
4.9 Comparison between PHAST and TRF 
Although it has long been known that critically short telomeres can have an outsized impact 
on cell phenotype, what constitutes this critical threshold has, frustratingly, been poorly defined. 
This is primarily due to the absence of tools that can reliably size short telomeres. We have found 
only one study that determined, using STELA and sequencing, that XpYp/17p fusion occurs below 
a minimal threshold of 13 hexanucleotide repeats, which is needed for telomeres to function 
normally [137]. However, the method is not widely used, possibly due to the laborious and specific 
nature of the methodology. Nevertheless, the study confirms that a physical limit on functional TL 
exists, below which the protective functions of telomeres are lost, perhaps due to insufficient 
binding of telomeric repeat binding factors (e.g. TRF1, TRF2) [137]. So far, the only conventional 
measurement method that can routinely provide estimates for absolute TL is TRF.  
TRF followed by Southern blotting is one of the most commonly used methods for 
telomere sizing. It is an elegant method for measuring the size of telomeres that takes advantage of 
the persistence of the canonical hexanucleotide (TTAGGG) repeats in the presence of restriction 
enzymatic activity [148]. It is one of very few methods that can yield any actual absolute telomeric 
size information, and is particularly useful when comparing the changes to the TL in a cell 
population over time. However, since the length of the final telomere-containing molecule depends 
on the proximity of the nearest restriction site to the telomere sequence, the length of this non-
canonical sub-telomeric region varies from chromosome to chromosome (Figure 4.10A, B). 
Consequently, a strong signal on a particular position on the gel may be due to a large number of 
short telomeres with long non-telomeric regions, or a small number of long telomeres with short 
non-telomeric regions. TRF/Southern blotting is unable to distinguish between these two cases. On 
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the other hand, telomere sizing by PHAST utilizes only the fluorescence intensity, which varies 
proportionately to the TL. Furthermore, since molecules are detected one at a time, PHAST can 
decouple the abundance and length of the telomere-containing fragments, thus yielding the actual 
TL distribution. 
To illustrate this, 2.4 kb telomeric sequence ligated into a plasmid vector was digested with 
RsaI/HinfI restriction enzyme mix, commonly used in TRF protocols. Gel electrophoresis shows 
the large shift in electrophoretic mobility that results from the loss of the non-telomeric region after 
digestion (Figure 4.10C). When tested with our method, the samples before and after digestion are 
virtually indistinguishable (Figure 4.10D). Since extracted genomic DNA typically consists of 
linear fragments, there is no need for any enzymatic digestion when performing PHAST. This also 
serves to eliminate any chance of encountering the “star activity” of the nucleases, where non-
specific cleavage occurs under sub-optimal reaction conditions and yields erroneous TL 
measurement [159]. 
Therefore, TRF is not ideal for determining the proportion of short telomeres. To test the 
suitability of PHAST for this task, we prepared mixtures of short (200 bp) and relatively long (900 
bp) telomeres at varying ratios. The short sub-population can be clearly distinguished in the 
histograms (Figure 4.8D). In addition, plotting the nominal fraction of 200 bp standards in each 
sample with the measured fraction yielded a linear fit with a gradient very close to one (Figure 
4.8E). The small offset in the observed fraction is attributed to incomplete labeling of a small 
proportion of the longer telomeres. It was reported that as few as five critically short telomeres out 
of 92 in a metaphase cell (i.e. ~ 5%) is sufficient to trigger the onset of senescence, highlighting 
the dominant effect of the shortest telomeres on cellular phenotype [126, 160]. The ability of 
PHAST to differentiate between the proportion of very short telomeres in the 0% and 5% samples 
demonstrates its suitability for this purpose. 
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We also compared HeLa telomere lengths determined using PHAST and that measured 
with TRF [161]. TRF and similar methods cannot decouple the abundance of telomeres from their 
lengths. As a result, longer telomere molecules can show up on the gel as more intense, even if they 
are less abundant than shorter DNA molecules. Therefore, when calculating the mean telomere 
length from TRF gels, it is common to use the equation 
Mean Telomere Length =∑𝑂𝐷 ∑(𝑂𝐷 𝑀𝑊⁄ )⁄                                     (16) 
where OD is the optical density or intensity on the gel, and MW is the molecular weight of 
the DNA, as calculated using DNA ladders [148, 162, 163]. However, the presence of a 
subtelomeric region that is resistant to restriction enzyme digestion, estimated to be around 2 kb 
[164, 165], means that the calculated mean telomere length will underestimate the abundance of 
short telomeres. 
To emulate TRF results, we binned the peaks detected on PHAST, and multiplied the 
abundance in each bin by the telomere length corresponding to the center of the bin. This yielded 
the intensity distribution, as might be observed on a gel, with the maximum intensity corresponding 
to a telomere length of 4.25 kb (Figure 4.11, blue). 
To account for the 2 kb subtelomeric, the histogram is shifted higher by 2 kb, and the mean 
telomere length is back-calculated using the above equation. This gives an estimated value of 5.0 
kb (Figure 4.11, black), which is a typically reported value. However, the actual mean telomere 
length is only 2.4 kb. In other words, the overestimation of average telomere length is even larger 
than the length of the subtelomeric region. Our estimate is also corroborated by a new 
electrophoresis-based method called TeSLA [166], which minimizes the length of the subtelomeric 
region, and gave an estimate of around 2.5 kb for HeLa cells. These results also highlight the 
difficulty in traditional methods for telomere measurement and argue for the need to introduce new 
and more convenient approaches. 
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4.10 Cell Numbers Needed for Telomere Sizing by PHAST 
To determine the number of cells necessary to obtain a good estimate of the telomeric 
distribution in a sample, we used Q-Q plots to compare the distribution of varying numbers of 
telomeres – corresponding to around 5, 10, 20 and 50 cells – against that of approximately 100 cells 
(10,000 telomere-containing DNA molecules, Figure 4.12). Since typical q-FISH uses only around 
10 metaphase spreads (corresponding to 1840 telomeric ends) to estimate the telomere distribution, 
we consider 100 cells more than sufficient to represent the TLs in a sample. A linear curve-fit is 
applied to the Q-Q plot in each case, and the residuals is used to estimate the goodness of fit.  
While the linear fit is relatively good in each case, the residuals become smaller (closer to 
zero) as the number of cell equivalents increased from 5 to 50. We find that at ~1,900 peaks 
(corresponding to 20 cells, Figure 4.11C), the TL distribution is very similar to that of the 100-cell 
sample. Since this is also close to the typical number of telomeric ends in q-FISH, we collect 1,900 
or more peaks for all our samples, unless otherwise stated. 
4.11 Comparison between PHAST and q-FISH 
In general, PNA binding to the target DNA is not only very robust, but also highly 
sequence-specific, as evidenced by large changes in melting temperatures resulting from single 
nucleotide mismatches [167, 168]. However, total genomic DNA contains a large excess of non-
telomeric sequences. In a typical patient sample, telomeric DNA (~8 kb per chromosomal arm, or 
0.75 Mb per cell) constitutes only around 0.01-0.02% of the total genomic DNA (~ 6 Gb). 
Consequently, we found that even the limited non-Watson-Crick interactions between PNA and 
DNA can yield an unacceptably high fluorescence background which can obscure short telomere 
peaks (< 300 bp) [169].  
PHAST utilizes a one-tube purification protocol to remove practically all non-telomeric 
DNA molecules, without biasing the TL distribution (Figures 4.5, 4.6, and 4.9). Extracted DNA 
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from cell lines (WI38, U2OS and R83) was purified using this method, and analyzed by PHAST. 
Because of the 100% mass detection efficiency, there is minimal sampling bias and a reasonably 
good estimate of the TL distribution is obtained with as few as 5 cell equivalents (~ 500 peaks, 
Figure 4.12). However, since the estimate improves with the number of sampled peaks, at least 
1,900 peaks are collected in each sample derived from cells, corresponding to 20 genomic 
equivalents (or 10 metaphases). The sizing results using PHAST is compared with those from q-
FISH for up to 30 cells using quantile-quantile (Q-Q) plots, which permits comparison of 
distributions of different units, with different number of elements (Figure 4.8F). For all 3 cell lines, 
the correlation between the PHAST and q-FISH results was largely linear, indicating that the 
measured telomere distributions were of the same shape for both methods.  
Since q-FISH is unable to provide absolute size of telomeres, we converted the q-FISH 
telomere fluorescence intensity units (TFU) to telomere length by scaling the TFU to match the 
modal values between PHAST and q-FISH. The resulting distributions from the two methods were 
found to be similar. The mean TL, and fractions of short (< 0.1 times mean TL) and long telomeres 
(> 3 times mean TL) are tabulated (Table 4.2). For each cell line, the fraction of long telomeres 
and mean TL were essentially the same for the two methods.  
Although PHAST consistently identifies fewer short peaks than q-FISH, the difference is 
most likely artificial. This is because q-FISH yields TFU values ranging from zero to thousands, 
with some of these short peaks (<2% of total) corresponding to telomere lengths shorter than the 
PNA probe (18 nt), based on the scaling used to normalize the distribution to PHAST. The presence 
of these extremely short telomeres may be due to variable detection efficiency across the imaging 
field in q-FISH, and suggests caution when interpreting q-FISH results for very short telomeres. It 
also explains the practical detection limit of 150-300 bp commonly cited for q-FISH [136], and 
likely accounts for the difference between the two distributions at the lower end of the range (< 400 
bp), where q-FISH may underestimate the length of the short telomeres. Since a cut-off of 65 bp 
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(corresponding to up to 3-4 bound PNA probes) is imposed for PHAST during thresholding to 
minimize detection of spurious peaks from the data, we placed a similar cut-off on the distribution 
from q-FISH, and found that the difference between the two methods was reduced (Table 4.2). 
Given the differences in the sample preparation, signal acquisition, and data handling, the 
agreement between the two methods is better than one might expect, and validates the PHAST 
method. 
Clinical samples (two from cancer patients, one from a control subject) were collected and 
tested by both PHAST and q-FISH (Figure 4.13). We found that both methods yielded distributions 
that were not significantly different between the control and patient samples. This is not unexpected, 
since there is no simple relationship correlating telomere biology to cancer incidence. However, by 
analyzing larger patient cohorts, in a further study, and controlling for various parameters, it may 
be possible elucidate the role of telomere length in cancer. 
4.12 Shortening of Telomeres with Population Doubling 
While commercial, immortalized cell lines including those in the previous section often 
possess some form of telomere lengthening or maintenance mechanism, other cell types, including 
primary cells, experience significant telomere shortening with each cell division, eventually leading 
to the onset of senescence. To verify our ability to detect such changes, excised human foreskin 
fibroblasts were cultivated for 38 population doublings (PD), and the cells were collected at various 
stages. PHAST was performed on the cells at PD = 8, 20, 32 and 38, while q-FISH was performed 
at PD = 8, 14, 20, 26, and 32 (Figure 4.14). At PD = 38, the cell division happens so infrequently 
that no metaphase could be obtained for q-FISH. Comparing the results for the two methods, we 
noticed that both showed shortening trends in the telomere length. Moreover, extrapolation of the 
PHAST results suggests that the initial telomere length (PD = 0) was approximately 8-9 kb (Figure 
4.14C(i)), which is a reasonable estimate corroborated by existing flow-FISH data [146]. The 
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estimated median telomere length at PD →  (i.e. at senescence) is around 2 kb, which is close to 
that theorized by the leading experts in this field [124, 170]. While these extrapolated estimates are 
not meant to be quantitative, the fact that they lie within the expected range further suggests that 
our telomere measurements are at least reasonably accurate. 
One somewhat surprising observation was that at PD = 8 and 14, the telomere length 
determined using q-FISH was significantly shorter than expected, resulting in a kink in the trend. 
One possible explanation for this is heterogeneity of the cells in culture, where a small 
subpopulation of cells (potentially of a different type) divides rapidly early on and approaches 
replicative senescence, before a second, relatively slow-dividing subpopulation takes over. Because 
q-FISH analysis can only be applied to actively proliferating cells (since cells must be arrested in 
metaphase prior to probe hybridization) [145, 171], it may be detecting only the early subpopulation, 
for which the actual number of cell divisions may be far larger than the nominal PD values. On the 
other hand, because PHAST measures the telomere lengths of all the cells within a sample, it suffers 
from no such bias. This hypothesis is supported by the PHAST results, which show a secondary 
peak corresponding to short telomeres (Figure 4.14A(i), black arrow). As a result, the telomere 
length as determined by q-FISH may underestimate the telomere length for the whole population. 
4.13 Application to Huntington CAG Tandem Repeats 
Our method is expected to be applicable to other types of tandem repeats. To demonstrate 
this, we chose to test out the Huntington CAG trinucleotide repeat, one of the most well-known 
tandem repeats. In Huntington’s Disease (HD) patients, the number of repeats range from 37 to 86, 
with the age of onset inversely related to the repeat length [59, 172]. For this experiment, we 
procured 12-nt PNA probes labeled with Alexa488 dye (PNA Bio), We also ordered an 
oligonucleotide that contained CAG repeats, that can bind a maximum of 16 probes (192 base long). 
The average repeat length measured by our method is 195 bases (Figure 4.15).  Although the 
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coefficient of variation is somewhat higher than that achieved for telomeres, this is attributed to the 
need to optimize the sample preparation process, which lies beyond the scope of this chapte. 
4.14 Conclusion 
This chapter has demonstrated a powerful method to determine the distribution of telomere 
lengths within a population of cells. Apart from routine DNA extraction, the entire sample handling 
process for PHAST can be completed within 2-3 hours. It addresses needs that are not met by two 
FISH-based methods that have emerged as leading candidates for telomere measurement, namely 
Flow-FISH and q-FISH.  
Although Flow-FISH provides a useful clinical index for studying telomere-related disease 
states, the fact that it has to take into account the age of the subject suggests that the average TL 
information obtained is, at best, a proxy for the underlying biological trigger, most likely the 
accumulation of critically short telomeres. Therefore, it will fail to identify cases wherein the 
telomere distribution deviates from what is typical, either due to a broader distribution (Figure 
4.1A(ii)), or catastrophic loss of telomeres (Figure 4.1A(iii)). The ability to test the TL in just non-
adherent cells, rather than in relevant parenchymal cells [147], also limits its utility in 
understanding the role of telomeres in the development of many cancers.  
On the other hand, q-FISH can determine not just TL distribution, but also chromosome-
specific TL [145, 173]. However, chromosome-specific telomere sizing may be extraneous since 
the biological effects of telomeres appear to be exerted primarily by the shortest telomeres, 
regardless of the chromosomal arms on which they are located [133]. thermore, the requirement for 
live cells that can be induced into metaphase precludes using the method on archival samples or 
senescent cells. Even when applicable, q-FISH is still an extremely laborious technique, taking 
hours to days to process a single sample, which often needs to be cultured and synchronized [136, 
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145]. Lastly, q-FISH provides the telomere lengths in TFU, rather than actual telomere length, 
making comparison across experiments particularly difficult.  
In contrast, the PHAST assay is capable of providing TL distribution for dividing or 
senescent cells; adherent or non-adherent cells; and frozen cell pellets or extracted DNA from 
sample banks. To our knowledge, PHAST is also unique in its ability to provide absolute telomere 
size distribution without needing concurrent measurement of standards, making it far more 
convenient. Because PHAST does not depend on any specific properties of the telomeric structures, 
instead taking a simple hybridization approach, it can be extended to other tandem repeats, many 
of which are implicated in severe neurological syndromes including Huntington’s disease [172, 
174] (Chapter 4.13). Length variations in these sequences have also been implicated in the rapid 
morphological changes in the domesticated dog [175]. While existing tandem repeat assays can be 
performed fairly routinely, they still suffer from technical and biological challenges including large 
allele dropout and null alleles that may be caused by primer site mutation [176, 177]. As a result, 
tandem repeats remain an underexplored field, with the vast majority of studies focusing on short 
microsatellites [178, 179]. In such instances, a PHAST-based approach can be advantageous in 
enabling detection without regard for the flanking sequences, and also eliminating biases arising 
from the amplification process. Furthermore, PHAST performs better for longer repeats (e.g. > 200 
bp), and thus complements the existing approaches for analyzing tandem repeats. 
In summary, we have demonstrated a new method that is able to determine the length of 
telomeres in extracted DNA rather than whole cells. By utilizing a powerful single molecule 
detection approach, this allows us to determine the length of individual telomere molecules, the 
load of critically short telomeres, and the distribution of telomere lengths in a sample, rather than 
merely average telomere lengths. This confers to it many of the advantages of q-FISH, but still able 




Figure 4.1. Principle of telomere measurement by PHAST 
(A) The biological effects of telomeres are mediated primarily by the proportion of telomeres below 
a critical length. (i) This most commonly happens in ageing, where the telomeres in a cell 
population shorten with doubling. However, the proportion of short telomeres can also reach critical 
levels when the average telomere length is normal. (ii) This can happen due to the naturally 
occurring diversity in the shape of the distribution between individuals, or (iii) if the telomere 
distribution is highly heterogeneous. (B) To perform our assay, cells are lyzed to release the DNA 
from the nucleus and incubated with biotinylated PNA probes. Telomeric DNA is separated from 
genomic DNA using magnetic beads, and released after washing, whereupon fluorescent probes 
are hybridized to the telomeric sequences. (C) The labelled DNA is then flowed through a 
microchannel, and excited by a laser through an objective as it transits the observation volume 
(OV). These peaks can then be processed to yield the telomere distribution. Adapted with 






Figure 4.2. Analysis of PHAST data 
(A) A fluorescent molecule is detected when a pre-determined threshold is exceeded. Each peak 
can be characterized by its Height, Width and total photon count, or Size, as illustrated. (B) Due to 
noise in the detector, the fluctuation in the background can occasionally exceed the threshold, 
whereupon a spurious peak, characterized by signal levels that hover around the baseline, and 
frequently large Width for any given Size, is detected. These spurious peaks can be removed by 
using a sufficiently high threshold, at the expense of assay sensitivity. (C) Alternatively, upon 
plotting on a log(Size)-log(Width) plot, the peaks form two distinct clusters which can be separated 
by gating (Chapter 4.6). (D) The real signal (red trace) can thus be distinguished from the spurious 
peaks (black trace), even when the shortest real peaks are shorter than the tallest spurious ones, as 
evidenced by the overlap between the two distributions. This cannot be achieved using a simple 
thresholding approach. (E) Although the Size parameter is, in principle, the most complete measure 
of the number of fluorophores on each telomere molecule, it is heavily dependent on the flow 
velocity. In fact, each Width-Size coordinate uniquely describes a telomere of a particular length, 
passing through the detection volume at a given velocity. (F) On the other hand, the Height 
parameter is very insensitive to flow velocity, with only a 10% decrease in the height when the 
velocity increases 8-fold (driving pressure scales linearly with inverse velocity). As such, the peak 
height is selected as the measure of telomere length. Adapted with permission from [180]. 





Figure 4.3. Single-molecule fluorescence peak profile 
The peak profile is the result of the convolution of the fluorophore distribution profile and OV 
profile. Depending on the relative sizes of these two contributing factors, the resulting profile can 
be parabolic, Gaussian or intermediate between the two in shape. Adapted with permission from 





Figure 4.4. Comparison between the experimental and predicted peak heights and widths 
Comparison between the experimental and predicted peak heights and widths based on the model 
(Chapter 4.4) demonstrates the remarkable agreement between the two. Experimental results were 
obtained from Hind III digested λ DNA labeled with TOTO-3. Adapted with permission from [180]. 






Figure 4.5. Overview of the PHAST purification protocol and performance 
This figure shows the one-tube sample preparation for PHAST assay at the sampling handling 
(Steps (I)-(VI)) and molecular levels (Panels A-D). Telomere-containing DNA is purified by 
incubation with the pull-down probe, pcTel-Bio, before using streptavidin-coated magnetic beads 
to remove it from solution (Steps (I)-(II)). The supernatant containing genomic DNA is then 
removed and the beads are washed (Step (III)). At this point, the telomere-containing DNA is left 
on the beads (Panel B). Next, the fluorescent PNA-AF488 is introduced at 100-fold excess 
compared to the pcTel-Bio (Step (IV)). This ensures that even if free pcTel-Bio were present, the 
PNA-AF488 can successfully label the telomere DNA. Heating the sample up to 85 °C then allows 
the DNA to simultaneously detach from the beads, and hybridize to the fluorescent probes (Panels 
C-D). To minimize competition from the now free pcTel-Bio on the beads, the 2-hour incubation 
at room temperature is performed on a magnetic holder (Step (V)). The sample can now be column-
purified and tested on CICS (Step (VI)). The purified sample yields fluorescent peaks on CICS, 
which can then be binned and plotted on a histogram (Panels E-F). Adapted with permission from 






Figure 4.6. Performance of the pull-down assay 
(A) Gel electrophoresis of genomic DNA spiked with 2.4 kb telomere standards showed intense 
fluorescence over a broad range of DNA lengths. After pull-down, the very intense smear at the 
bottom of the gel is almost completely removed. The telomere standards (white dashed box) can 
be clearly seen. Long genomic DNA fragments were also recovered via non-specific interaction 
with the streptavidin-coated beads, though not in sufficient quantities to affect the signal-to-noise 
ratio of PHAST. (B) Raw signal traces for the sample before and after the pull-down assay show 
the effect of non-specific hybridization. Although the specificity of the PNA probes ensure that the 
increase in the background is manageable, the proximity of the background level to the threshold 
results in a significant number of peaks (red arrows) that cross the threshold. These correspond to 
a TL of around 65 bp, and their sheer numbers skews the resulting telomere size distribution. (C) 
After pull-down, the background returns to a level comparable to the genomic DNA-free standards. 
(D) Comparison of the pull-down at different concentrations show that at low concentrations 
comparable to that found naturally, the efficiency is uniform across different TLs (blue). However, 
when the concentration of telomeres is very high (~100-fold higher), longer telomeres are 







Figure 4.7. Gating strategy for PHAST 
The burst sizes and widths for the peaks in a sample are plotted. The gating is performed by 
selecting the cluster of peaks that has a smaller slope (A). The various plots show the relationships 
between the different parameters (A-C). The final TL distribution can be calculated from the height 
distribution (D) using a simple linear formula. Adapted with permission from [180]. Copyright 






Figure 4.8. Telomere length (TL) determination using peak height 
(A) Peak height is converted to TL using a simple linear equation derived from telomere standards 
of known lengths. The resulting three sets of TL estimates are nearly identical despite having been 
performed at 6-month intervals, with high linearity (R2 > 0.99). This reproducibility demonstrates 
the ability of PHAST to provide absolute telomere lengths with minimal calibration. (B) The six 
standards can be distinguished from each other by PHAST even when pre-mixed prior to detection, 
and have a smaller CV as the TL increases, as evidenced by the narrowing of the distributions with 
longer TL. (C) We have demonstrated the robustness of PHAST, by detecting a 2.4 kb telomere 
standard with and without a large excess of genomic DNA. Because the spurious peaks far 
outnumber the real peaks (by a factor of 10 to 1), the traces are normalized for clarity. After gating, 
the sample with genomic DNA (red solid trace) was essentially the same as that without any 
genomic DNA (black dashed trace). (D) To determine the ability to detect short telomeres using 
PHAST, 200-bp telomere standard is mixed at varying proportions with the 900-bp standard (0-
50%). (E) After gating and counting the two sub-populations, the measured proportion was plotted 
against the nominal proportion. The two numbers were very consistent, with a slightly higher 
proportion measured than expected. This is attributed to incomplete labeling of some of the longer 
telomeres, which are misidentified as short telomeres. (F) Q-Q plots for the telomere estimates 
determined by PHAST and q-FISH are presented with three different cell lines (WI-83, U2OS, and 
R83). This allows the distributions between two measurement methods to be compared directly 
even in the absence of common units and when the number of data points differs. Although PHAST 
and q-FISH are different methods, they yielded similar distribution shapes, as evidenced by the 
largely linear relationship between the corresponding quantiles. The red dashed line in each plot is 
the extrapolation of the interquartile range. Adapted with permission from [180]. Copyright 2019 





Figure 4.9. Testing of pull-down process for long telomeres 
(A) The padlock probe chemistry in conjunction with rolling circle amplification is employed to 
generate long DNA molecules containing telomeric sequences to simulate long telomeres for our 
pull-down assay. (B) The linearity of the Q-Q plot of telomere distribution determined by PHAST 
before and after the pull-down demonstrates that our process did not bias the telomere size 





Figure 4.10. Advantage of PHAST over TRF analysis by Southern blot 
(A) Genomic DNA is digested by restriction enzymes, while telomeric DNA, which do not contain 
the restriction sites, remain intact. Differing lengths of sub-telomeric DNA remains on the molecule, 
depending on the proximity of the restriction site closest to the telomeres. (B) As a result, TRF 
overestimates the TL by varying degrees. In this schematic, telomeric DNA of identical sizes are 
misidentified as three molecules of different sizes, resulting in inaccurate length estimates. On the 
other hand, since telomere fluorescence intensity on PHAST is solely determined by the length of 
the telomeric sequence, the TL measurement is representative of the underlying TL distribution. 
(C) To simulate the effects of TRF on the telomere sizing, we digested 2.4 kb telomere standards 
in linearized plasmids with RsaI/HinfI restriction enzyme mix (gray dotted box). The large band 
shift can be clearly seen, highlighting the inability of TRF Southern blot to distinguish between the 
lengths of the telomeric and non-telomeric portions in a DNA molecule. In an actual sample, the 
shifted band will be far less well-defined, since the undigested sub-telomeric region will vary 
greatly in length, depending on the sequence of the DNA. (D) When we tested the same samples 
using PHAST, it is clear that the frequency (y-axis) of telomere fluorescence (x-axis) is essentially 






Figure 4.11. HeLa telomere lengths determined using PHAST 
This figure presents the normalized abundance (blue) and intensity (black) of the telomere 
distribution, as determined by PHAST. The Intensity curve emulates the results from TRF, and 






Figure 4.12. Determination of the number of telomeres needed to adequately represent the 
distribution 
Q-Q plots are employed to compare the distribution of varying numbers of telomeres – 
corresponding to around 5 (A), 10 (B), 20 (C) and 50 (D) cells – against that of approximately 100 
cells (10,000 telomere-containing DNA molecules). The linear fit is relatively good in each case, 
and the residuals become smaller (closer to zero) as the number of cell equivalents increased from 






Figure 4.13. Clinical sample tests by PHAST and q-FISH 
(A) Q-FISH measurements do not show obvious differences in telomere distribution between the 
cancer patient samples (BA01628 and BA01650) and control sample (CB3319). (B) Similarly, 
PHAST measurements do not show obvious differences in telomere distribution between the cancer 
patient samples (BA01628 and BA01650) and control sample (CB3319). Adapted with permission 






Figure 4.14. Detection of telomere shortening in primary cells with population doubling (PD) 
(A) Telomere shortening can be observed going from PD = 8, 20, 32, to 38 (i-iv). A sub-population 
of short telomeres was also observed at PD = 8. (B) The Q-Q plots for PD = 8, 20 and 32 between 
PHAST and q-FISH. Since these samples were normalized with the same standards for q-FISH to 
obtain the TFU, one would expect all three to have the same slopes. However, the slope for PD = 
8 (2.2 x 10-3) is around twice that of the other samples (1.0 x 10-3 and 1.2 x 10-3 for PD = 20 and 
PD = 32, respectively). This suggests that the TL determined by q-FISH is around half as long as 
expected from the PHAST results. (C) This difference is further confirmed by plotting the TL 
measurements against PD. (i) The median PHAST TL estimates (black dashed lines) were fitted to 
an exponential function. By setting the PD to 0 and ∞, we obtain TL estimates for the original 
patient cells and the cells at senescence, which are around 8-9 kb and 2 kb, respectively. (ii) The q-
FISH results showed some degree of shortening at late passages (20-32), but stayed relatively 
constant at early passages (PD 8 and 14). The dashed lines show the trend an exponential decay 
might be expected to follow. The shorter than expected TL at low PDs is most likely the result of 







Figure 4.15. Huntington repeat length measurement using PHAST 
Figure 4.15 Application of the method to CAG trinucleotide repeat associated with Huntington’s 
Disease yields a good estimate. However, further optimization is needed to reduce the coefficient 
of variation for this sample/probe combination. Adapted with permission from [180]. Copyright 








Set 1 (kb) 
TL Estimates 
Set 2 (kb) 
TL Estimates 
Set 3 (kb) 






0.1 0.09  0.01 0.08  0.01 0.10  0.01 11.0% 0.08  0.02 
0.2 0.19  0.04 0.19  0.05 0.21  0.03 6.8% 0.22  0.03 
0.4 0.39  0.06 0.34  0.05 0.40  0.07 9.0% 0.41  0.05 
0.9 0.97  0.12 0.96  0.15 0.92  0.15 3.7% 0.91  0.14 
1.2 1.25  0.14 1.17  0.14 1.28  0.15 4.4% 1.29  0.16 





Table 4.1. CVs for Telomere Standards on CICS 
TL is calculated based on peak height using a simple linear equation derived from telomere 
standards of known lengths (Chapter 4.8). The resulting three sets of TL estimates have shown 
great reproducibility, which are nearly identical despite having been performed at 6-month intervals. 
The TL estimates has a CV of around 10-25%, with greater uncertainty for shorter telomeres. 





 WI-38 R83 U2OS 
 
PHAST, 
n = 47a 
q-FISH, 
n = 32 
PHAST, 




n = 57a 
q-FISH, n 
= 30 









% Long Telomeres 4.8 4.7 1.7 1.5 2.0 0.9 
Mean TL (kb) 6.0 5.8 3.2 3.6 5.4 6.0 
a Genomic equivalents of telomere molecules detected, derived by dividing total peak count by 92, 
corresponding to p and q arms on each of 46 chromosomes. 






Table 4.2. Comparison between PHAST and q-FISH for telomere measurement in cell lines 
Relative abundance of long and short telomeres are determined by PHAST and q-FISH, for WI-38. 
R83 and U2OS cell lines. For each cell line, the fraction of long telomeres and mean TL were 
essentially the same for the two methods. Adapted with permission from [180]. Copyright 2019 







We have developed an advanced platform for multiplexed analysis of nucleic acid 
including a silica nanomaterial-based method for high molecular weight DNA extraction,  a new 
multiplexed nucleic acid detection approach termed Ratiometric Fluorescence Coding and a single-
molecule fluorescence spectroscopic method for measuring telomere length.  
First, we have developed a novel magnetic thermoplastic silica nanomaterial named 
Nanobind, using a simple heat-shrinking process to create a high density of micro- and nano-scale 
silica lamella capable of capturing a vast amount of DNA and harbor it from fragmentation. The 
Nanobind extraction takes only 45 minutes using a simple bind, wash and elute process, which 
incorporates a tentacle binding mechanism to obtain DNA >5.7 Mb in length with binding 
capacities up to 1,000,000-times greater than silica paramagnetic particles. A thorough comparison 
against the three most commonly used DNA extracted methods (phenol-chloroform,  spin column 
and paramagnetic particles) has been performed and demonstrated the Nanobind method enables 
high yields, high quality and high molecular weight DNA far surpassing that of any existing silica 
technology. When this DNA was used for single molecule sequencing, the high molecular weight 
and low DNA damage generated exceptional quality long-read libraries and lead to some of the 
longest reads seen to date on Pacific Biosciences’ platform. 
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Secondly, we have developed a Ratiometric Fluorescence Coding strategy for expanding 
the multiplexing capacity of NAATs by encoding each nucleic acid target with a specific 
fluorescence ratio. Using our strategy, we have demonstrated the detection of six gene sequences 
for infectious diseases using only two distinct fluorophores. This is achieved by assigning each 
nucleic acid target with a specific number of binding sites for two probes labeled with fluorophores 
of distinct colors via padlock chemistry and RCA/HRCA reactions. By coupling our strategy with 
droplet-based microfluidic system, we have demonstrated our platform for multiplexed detection 
of gene sequences from six STDs, and the highly resolved fluorescence ratios for distinct targets 
offer the potential for detecting even more gene sequences using the same fluorescent probes. 
Lastly, we have developed a single molecule spectroscopic method, PHAST, for 
determining the distribution of telomere lengths in any DNA sample by hybridizing fluorescently 
labeled PNA to the canonical telomere sequence, flowing the molecules through a microfluidic 
device, and detecting each on a confocal spectroscopic instrument one-at-a-time as fluorescence 
peaks. Our PHAST is analogous to flow cytometry, albeit at the molecular scale, and as in flow 
cytometry, each detected peak is gated according to its shape parameters to distinguish real signals 
from spurious ones. We have demonstrated PHAST for reproducible measurement of absolute 
telomere lengths rather than merely average lengths in various DNA sample including cancer cell 
lines, primary cells and clinical samples. This powerful single molecule detection approach also 
been demonstrated for determining the load of critically short telomeres and the length of individual 
telomere molecules with DNA from small numbers of cells. 
5.2 Future Directions 
So far, the commonly used approach for de novo sequencing is next-generation sequencing 
(NGS), which, however, only produces read lengths around hundreds of nucleotides. This causes 
substantial challenges in sequencing large complex genomes (such as repetitive sequences over 
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10kb) because de novo assemblies based on these short reads generate fragmented genome 
sequences and misassembled rearrangements [181]. The 3rd generation sequencing with read 
lengths over 10kb, such as SMRT and Nanopore technology, will improve the assembly of complex 
genomes but high molecular weight DNA is required to fully benefit from these technology. This 
thesis has demonstrated that our Nanobind extracted DNA has ultra-high molecular weight with 
high purity, making it perfect sample for 3rd generation sequencing. Coupling Nanobind extraction 
with 3rd generation sequencing will potentially enable de novo assembly of large complex genomes 
and allow access to preciously inaccessible regions of genomes. Furthermore, because the 
underlying polyolefin film costs pennies per square foot and the fabrication can be easily scaled 
using industrial roll-to-roll processes, our Nanobind is exceptionally inexpensive to produce. 
Considering the fact that our extraction takes a short 45 minutes process time using our own custom 
buffers, Nanobind can be easily manufactured as a commercial DNA extraction kit and applied for 
a broad array of samples including bacterial and plant cells, tissues, body fluids, and formalin-fixed 
paraffin embedded (FFPE) sample. In addition, since the magnetic layer on Nanobind allows 
automated sample processing using a robotic instrument, it can be potentially integrated onto 
microfluidic systems for on-chip sample preparation. 
PHAST method demonstrated in the thesis for telomere length measurement provides an 
alternative approach for analysis of repetitive sequences in the genome. Because PHAST does not 
depend on any specific properties of the telomeric structures, instead taking a simple hybridization 
approach, it can be potentially extended to other tandem repeats, such as trinucleotide repeat 
sequences in Huntington or TERRA (telomeric repeat-containing RNA) [182]. 
In the past decades, there has been a rapid progress in multiplexed nucleic acid diagnostics 
for human diseases and it is clear their application will become more mainstream in the near future. 
In this thesis, our Ratiometric Fluorescence Coding strategy has been demonstrated to expand the 
multiplexed detection capacity of NAATs and can readily achieve higher multiplexing capacity by 
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designing more fluorescent probe binding sites or using more fluorescence colors. We can easily 
add one more fluorescent probe with distinct color and arrange up to five probe binding sites on 
each padlock probes, which will potentially enable up to 40-plex detection using 3 different 
fluorescent probes. Moreover, since only the ratios of fluorescent probe hybridization sites are 
designed to vary but the sequences of the hybridization sites remain the same, the same set of 
fluorescent probes can be used for detecting different targets, independent of the target sequences. 
Therefore, we can easily expand the application of our Ratiometric Fluorescence Coding methods 
for other molecular diagnostics such as DNA methylation and RNA profiling.  In addition, besides 
rolling circle amplification, our Ratiometric Fluorescence Coding can also be coupled with other 
nucleic acid amplification techniques, such as LCR and PCR (potentially better sensitivity), and 
integrated onto digital microfluidic devices or single molecule detection system for highly 
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